JP2002275080A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2002275080A JP2002275080A JP2001080389A JP2001080389A JP2002275080A JP 2002275080 A JP2002275080 A JP 2002275080A JP 2001080389 A JP2001080389 A JP 2001080389A JP 2001080389 A JP2001080389 A JP 2001080389A JP 2002275080 A JP2002275080 A JP 2002275080A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- cranberry fruit
- acid
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 239000000284 extract Substances 0.000 claims abstract description 184
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 67
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 66
- 235000004634 cranberry Nutrition 0.000 claims abstract description 66
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 33
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 239000012190 activator Substances 0.000 claims abstract description 11
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 11
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 11
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract 10
- 235000015203 fruit juice Nutrition 0.000 claims description 33
- 230000002087 whitening effect Effects 0.000 claims description 32
- 239000003112 inhibitor Substances 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims 1
- 239000007844 bleaching agent Substances 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 230000003405 preventing effect Effects 0.000 abstract description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 4
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000004061 bleaching Methods 0.000 abstract 1
- 230000002542 deteriorative effect Effects 0.000 abstract 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 58
- -1 -Propanol Chemical compound 0.000 description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 26
- 235000019441 ethanol Nutrition 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 17
- 239000000843 powder Substances 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 15
- 239000000194 fatty acid Substances 0.000 description 15
- 229930195729 fatty acid Natural products 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000003755 preservative agent Substances 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 14
- 235000019437 butane-1,3-diol Nutrition 0.000 description 14
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 239000008213 purified water Substances 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000002335 preservative effect Effects 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 230000002500 effect on skin Effects 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 239000010419 fine particle Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- 229960000541 cetyl alcohol Drugs 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000010445 mica Substances 0.000 description 7
- 229910052618 mica group Inorganic materials 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000011787 zinc oxide Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 206010014970 Ephelides Diseases 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 206010042496 Sunburn Diseases 0.000 description 5
- 235000006468 Thea sinensis Nutrition 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- 239000009538 yokuinin Substances 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 241001474374 Blennius Species 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 229940008396 carrot extract Drugs 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 3
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 235000011201 Ginkgo Nutrition 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 235000017309 Hypericum perforatum Nutrition 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 235000004347 Perilla Nutrition 0.000 description 3
- 244000124853 Perilla frutescens Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 241001647091 Saxifraga granulata Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 244000274883 Urtica dioica Species 0.000 description 3
- 235000009108 Urtica dioica Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 241001222097 Xenocypris argentea Species 0.000 description 3
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000005037 alkyl phenyl group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940089116 arnica extract Drugs 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 229950004580 benzyl nicotinate Drugs 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 235000020221 chamomile extract Nutrition 0.000 description 3
- 229940119217 chamomile extract Drugs 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 235000020237 cranberry extract Nutrition 0.000 description 3
- 229960002104 cyanocobalamin Drugs 0.000 description 3
- 235000000639 cyanocobalamin Nutrition 0.000 description 3
- 239000011666 cyanocobalamin Substances 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 3
- 229940108325 retinyl palmitate Drugs 0.000 description 3
- 235000019172 retinyl palmitate Nutrition 0.000 description 3
- 239000011769 retinyl palmitate Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- QHNVWXUULMZJKD-UHFFFAOYSA-N 3,4-didehydroretinal Chemical compound O=CC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C QHNVWXUULMZJKD-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- JWMBOBQNPBCYER-UHFFFAOYSA-N 4-[(4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound OC1C(CO)OC(O)C(O)C1OC1C(O)C(C2O)OCC2O1 JWMBOBQNPBCYER-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000499950 Arthropodium cirratum Species 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000001548 Camellia japonica Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000561734 Celosia cristata Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 description 2
- 240000000731 Fagus sylvatica Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 2
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241000945534 Hamana Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
- 244000141009 Hypericum perforatum Species 0.000 description 2
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 241000238371 Sepiidae Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 210000001520 comb Anatomy 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 229940038487 grape extract Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 235000014304 histidine Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000002814 niacins Chemical class 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 2
- 235000008979 vitamin B4 Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000003901 Crambe Nutrition 0.000 description 1
- 241000220246 Crambe <angiosperm> Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000105059 Geranium thunbergii Species 0.000 description 1
- 235000005491 Geranium thunbergii Nutrition 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- ZEWSVCOXUZRGDR-UHFFFAOYSA-N Pyridoxine dihydrochloride Chemical compound Cl.Cl.CC1=NC=C(CO)C(CO)=C1O ZEWSVCOXUZRGDR-UHFFFAOYSA-N 0.000 description 1
- 241000206608 Pyropia tenera Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 241000269959 Xiphias gladius Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940105039 coconut extract Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000003897 fog Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000453 juniperus communis l. leaf oil Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- BPHQIXJDBIHMLT-UHFFFAOYSA-N perfluorodecane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F BPHQIXJDBIHMLT-UHFFFAOYSA-N 0.000 description 1
- YVBBRRALBYAZBM-UHFFFAOYSA-N perfluorooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YVBBRRALBYAZBM-UHFFFAOYSA-N 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 235000021335 sword fish Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、クランベリー果実
搾汁液及び/又はクランベリー抽出物を含有する皮膚外
用剤に関し、更に詳細には、クランベリー果実搾汁液及
び/又はクランベリー抽出物を含有することにより、色
素沈着の予防及び改善ならびに肌の透明感を改善する美
白、美肌効果に優れた皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to an external preparation for skin containing a cranberry fruit juice and / or a cranberry extract, and more particularly to a cranberry fruit juice and / or a cranberry extract. The present invention relates to a skin external preparation having an excellent whitening effect and a beautiful skin effect for preventing and improving pigmentation and improving skin clarity.
【0002】[0002]
【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、洗浄料、分散液、軟膏、外用液剤等の皮膚外用剤
には、これらに所定の薬効を付与することを目的として
種々の薬剤が加えられている。例えば、日焼け等により
生じる皮膚の黒化、色素沈着により生ずるシミ、ソバカ
ス等を予防または改善するために、アスコルビン酸、胎
盤エキス、グルタチオン、ハイドロキノン等の美白剤が
加えられている。2. Description of the Related Art Conventionally, skin external preparations such as emulsions, creams, lotions, packs, cleansers, dispersions, ointments, and external preparations have been variously formulated with the aim of imparting a predetermined medicinal effect to them. Has been added. For example, whitening agents such as ascorbic acid, placental extract, glutathione, and hydroquinone have been added to prevent or improve skin darkening caused by sunburn and the like, and spots and freckles caused by pigmentation.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、これら
の美白剤では、美白効果が十分でなかったり、あるい
は、製剤中で変質するなどして所期の薬効が得られない
場合が多く、その改善が望まれていた。However, in many cases, these whitening agents do not have sufficient whitening effect or do not have the desired medicinal effect due to deterioration in the preparation. Was desired.
【0004】[0004]
【課題を解決するための手段】本発明者らは、皮膚外用
剤の薬効成分として使用することができる成分について
鋭意検討を行った結果、クランベリー果実搾汁液及び/
又はクランベリー果実抽出物が高いメラニン生成抑制作
用を有し、美白、美肌成分として優れたものであること
を見出した。そして、この抽出物は、美白、美肌成分と
して皮膚外用剤に配合できると共に、他の薬効成分と組
み合せることにより皮膚外用剤としてより優れた効果が
得られることを見出し、本発明を完成した。Means for Solving the Problems The present inventors have conducted intensive studies on components that can be used as medicinal components of an external preparation for skin, and as a result, found that cranberry fruit juice and / or
Alternatively, the present inventors have found that a cranberry fruit extract has a high melanin production inhibitory action and is excellent as a whitening and skin beautiful component. The present inventors have found that this extract can be blended with a skin external preparation as a skin whitening and skin beautiful component, and that a more excellent effect as a skin external preparation can be obtained by combining the extract with other medicinal components, thereby completing the present invention.
【0005】すなわち本発明は、クランベリー果実搾汁
液及び/又はクランベリー果実抽出物を美白、美肌成分
として含有することを特徴とする、色素沈着の予防及び
改善ならびに肌の透明感を改善する効果のある、優れた
美白効果を有する皮膚外用剤を提供するものである。[0005] That is, the present invention is characterized by containing cranberry fruit juice and / or cranberry fruit extract as a whitening and skin-smoothing component, and is effective in preventing and improving pigmentation and improving skin clarity. And a skin external preparation having an excellent whitening effect.
【0006】[0006]
【発明の実施の形態】本発明に用いられるクランベリー
は、シャクナゲ科ツルコケモモ属に属する植物で、学名
はVaccinium macrocorpon Ai
tonもしくはVaccinium oxycoccu
s、和名はツルコケモモである。つる性の常緑の細長い
茎を有する潅木で、花は白〜桃色で、赤色で光沢がかっ
た酸味の果実をつける。クランベリーは北米、南米を主
な原産としているが、本発明に用いられる搾汁液や抽出
物を得るにあたっては、その種類や産地は特に限定され
ない。BEST MODE FOR CARRYING OUT THE INVENTION Cranberry used in the present invention is a plant belonging to the family Rhododendron of the family Rhododendron.
ton or Vaccinium oxycoccu
s, Japanese name is Tsurukokemomo. A shrub with evergreen elongate stems on the vine, flowers are white to pink, with reddish, glossy, sour fruits. Cranberries are mainly derived from North and South America, but the kind and production area of the juice and extract used in the present invention are not particularly limited.
【0007】上記クランベリー果実搾汁液は、クランベ
リーの果実を破砕、摩砕等したものを、果皮や種子を除
去するために裏ごし、分離することにより得ることがで
きるが、さらにろ過清澄処理、酵素処理、濃縮処理、微
細化処理、脱臭脱色処理等を行っても良く、その調製法
は特に限定されない。得られた搾汁液は溶液状の他に必
要に応じてペースト状、ゲル状、粉末状とすることもで
きる。[0007] The above cranberry fruit juice can be obtained by crushing and grinding cranberry fruit, lining it to remove pericarp and seeds, and separating it. , Concentration treatment, fine treatment, deodorization and decolorization treatment, etc., and the preparation method is not particularly limited. The obtained juice may be in the form of a paste, a gel, or a powder, if necessary, in addition to the solution.
【0008】本発明においては、クランベリー果実搾汁
液の原液を様々な溶媒で希釈して用いることもできる。
溶媒としては、例えば水;メチルアルコール、エチルア
ルコール等の低級1価アルコール;グリセリン、プロピ
レングリコール、1,3−ブチレングリコール等の液状
多価アルコール等の1種または2種以上を用いることが
できる。または防腐対応のため、パラオキシ安息香酸エ
ステル、フェノキシエタノ−ル等の防腐剤の1種または
2種以上を加えて用いることもできる。In the present invention, the stock solution of cranberry fruit juice can be diluted with various solvents and used.
As the solvent, for example, one or more kinds of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol can be used. Alternatively, one or more preservatives such as paraoxybenzoate and phenoxyethanol can be added for preservative use.
【0009】また、本発明ではクランベリー果実の抽出
物も使用することができる。クランベリー果実抽出物は
クランベリー果実から種々の抽出溶媒を用いることによ
って得られる。その抽出方法に関しては特に限定されな
いが、適当な溶媒を用いて低温もしくは室温ないし加温
下で抽出される。クランベリー抽出物を得るための抽出
溶媒としては、例えば水、低級1価アルコール(メチル
アルコール、エチルアルコール、1−プロパノール、2
−プロパノール、1−ブタノール、2−ブタノール
等)、液状多価アルコール(グリセリン、プロピレング
リコール、1,3−ブチレングリコール等)、低級アル
キルエステル(酢酸エチル等)、炭化水素(ベンゼン、
ヘキサン、ペンタン等)、ケトン類(アセトン、メチル
エチルケトン等)、エーテル類(ジエチルエーテル、テ
トラヒドロフラン、ジプロピルエーテル等)、アセトニ
トリル等が挙げられ、1種または2種以上を用いること
ができる。In the present invention, an extract of cranberry fruit can also be used. Cranberry fruit extract is obtained from cranberry fruit by using various extraction solvents. The extraction method is not particularly limited, but the extraction is carried out using a suitable solvent at a low temperature or at room temperature or under heating. As an extraction solvent for obtaining a cranberry extract, for example, water, lower monohydric alcohol (methyl alcohol, ethyl alcohol, 1-propanol,
-Propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (glycerin, propylene glycol, 1,3-butylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.), hydrocarbons (benzene,
Hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, dipropyl ether, etc.), acetonitrile, etc., and one or more kinds can be used.
【0010】また、好ましい抽出方法の例としては、含
水濃度0〜100vol%のエチルアルコールまたは
1,3−ブチレングリコールを用い、室温で、または加
温して1〜5日間抽出を行ったのち濾過し、得られた濾
液をさらに1週間ほど放置して熟成させ、再び濾過を行
う方法が挙げられる。[0010] As an example of a preferable extraction method, ethyl alcohol or 1,3-butylene glycol having a water content of 0 to 100 vol% is extracted at room temperature or heated for 1 to 5 days, and then filtered. Then, the obtained filtrate is allowed to stand for about one week to be aged, and then filtered again.
【0011】本発明の皮膚外用剤におけるクランベリー
果実搾汁液及び/又はクランベリー果実抽出物の含有量
は、固形分として好ましくは0.00001〜5質量%
(以下単に「%」で示す)であり、より好ましくは0.
0001〜2%である。この範囲内であれば、クランベ
リー果実搾汁液及び/又はクランベリー果実抽出物を安
定に配合することができ、かつ高い美白、美肌効果を発
揮することができる。また、抽出液を使用する場合は、
溶質である固形分の含有量が上記範囲内であれば、その
抽出液濃度は何ら限定されるものではない。The content of the cranberry fruit juice and / or the cranberry fruit extract in the external preparation for skin of the present invention is preferably 0.00001 to 5% by mass as solid content.
(Hereinafter simply referred to as “%”), and more preferably 0.1%.
0001 to 2%. Within this range, the cranberry fruit juice and / or the cranberry fruit extract can be stably blended, and can exhibit high whitening and skin beautiful effects. When using an extract,
As long as the content of the solid content as a solute is within the above range, the concentration of the extract is not limited at all.
【0012】本発明のクランベリー果実搾汁液及び/又
はクランベリー果実抽出物は、これを美白、美肌成分と
して常法に従い、通常の皮膚外用剤に使用される種々の
形態の基剤に配合し、製剤化することにより皮膚外用剤
を得ることができるが、更に他の薬効成分と組み合せる
ことにより、より美白、美肌効果の優れた皮膚外用剤が
得られる。The cranberry fruit juice and / or cranberry fruit extract of the present invention is blended with various types of bases used in usual external preparations for the skin, according to a conventional method as a skin whitening and skin beautiful component. A skin external preparation can be obtained by making the composition into a skin, but by further combining it with other medicinal ingredients, a skin external preparation having more excellent skin whitening and skin effect can be obtained.
【0013】本発明においてクランベリー果実搾汁液及
び/又はクランベリー果実抽出物(成分(A))と組み
合わせ、使用される他の薬効成分(成分(B))は、美
白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤
から選ばれるものであるが、具体的な薬効剤としては、
それぞれ以下に示すものが挙げられる。尚、かっこ内
は、植物の別名、生薬名等を記載した。In the present invention, other medicinal ingredients (component (B)) used in combination with cranberry fruit juice and / or cranberry fruit extract (component (A)) are a whitening agent, an antioxidant, and an anti-inflammatory agent. Agents, cell activators, UV inhibitors, but as specific medicinal agents,
The following are respectively mentioned. In the parentheses, other names of plants, names of crude drugs, and the like are described.
【0014】(美白剤)美白剤としては、ビタミンC及
びその誘導体(L−アスコルビン酸リン酸エステル、L
−アスコルビン酸硫酸エステル、ジパルミチン酸L−ア
スコルビル、テトライソパルミチン酸L−アスコルビル
等)、胎盤抽出物、グラブリジン、グラブレン、リクイ
リチン、イソリクイリチン及びこれらを含有するカンゾ
ウ抽出物、ハトムギ(ヨクイニン)抽出物、コガネバナ
(オウゴン)抽出物、海藻抽出物(コンブ、マコンブ、
ワカメ、ヒジキ、ヒバマタ、スジメ、トロロコンブ、カ
ジメ、ツルアラメ、チガイソ、ホンダワラ、ジャイアン
トケルプ等の褐藻類;テングサ、ツノマタ、スギノリ、
ウスバノリ、アサクサノリ、マツノリ、トサカマツ、フ
ノリ、オゴノリ、カイメンソウ、イギス、エゴノリ等の
紅藻類;クロレラ、アオノリ、ドナリエラ、クロロコッ
カス、アナアオサ、カワノリ、マリモ、シオグサ、カサ
ノリ、フトジュズモ、タマジュズモ、ヒトエグサ、アオ
ミドロ等の緑藻類;スピルリナ等の藍藻類等)、ビャク
レン抽出物、センプクカ抽出物、ブドウ抽出物、コムギ
抽出物、トマト抽出物、カロチノイド(カロチン、リコ
ピン、アスタキサンチン等)、アガロース、オリゴサッ
カライド、ネオアガロビオース、ハイドロキノン及びそ
の誘導体、システイン及びその誘導体、アスパラガス抽
出物、イブキトラノオ抽出物、ノイバラ(エイジツ)抽
出物、エゾウコギ抽出物、エンドウ豆抽出物、カミツレ
抽出物、ケイケットウ抽出物、オレンジ抽出物、キイチ
ゴ抽出物、キウイ抽出物、クララ(クジン)抽出物、コ
ーヒー抽出物、ゴマ油、エゴマ油、ゴカヒ(エゾウコ
ギ)抽出物、コメ抽出物、サイシン抽出物、サンザシ抽
出物、サンペンズ(カワラケツメイ)抽出物、シャクヤ
ク抽出物、シラユリ抽出物、クワ(ソウハクヒ)抽出
液、トウキ抽出液、ブナ抽出物、ブラックカラント抽出
物、ホップ抽出物、マイカイカ(マイカイ、ハマナス)
抽出物、モッカ(ボケ)抽出物、ユキノシタ抽出物、茶
抽出物(烏龍茶、紅茶、緑茶等)、大豆抽出物、糖蜜抽
出物、羅漢果抽出物等が挙げられる。(Whitening agent) As whitening agents, vitamin C and its derivatives (L-ascorbic acid phosphate, L
-Ascorbic acid sulfate, L-ascorbyl dipalmitate, L-ascorbyl tetraisopalmitate), placenta extract, glabridine, glabrene, liquiritin, isoliquiritin, and a liquorice extract containing these, adlay (yokunin) extract, Scutellaria (Oregon) extract, seaweed extract (kelp, makombu,
Brown algae such as wakame, hijiki, hibamata, shimeji, trollocum, swordfish, truss arame, tigaiso, hondawara, giant kelp; tengusa, tsunomata, suginori,
Red algae such as Usubanori, Asakusanori, Matsunori, Tosakamatsu, Funori, Ogonori, Sponge, Eggis, Egonori, etc .; Green algae; blue-green algae such as spirulina), juniper extract, mushroom extract, grape extract, wheat extract, tomato extract, carotenoids (carotene, lycopene, astaxanthin, etc.), agarose, oligosaccharides, neoagarobiose, Hydroquinone and its derivatives, cysteine and its derivatives, asparagus extract, Ibukitorano extract, Neubara (Aegitsu) extract, Eleuthero extract, pea extract, chamomile extract, coconut extract C. extract, orange extract, raspberry extract, kiwi extract, Clara (Kudin) extract, coffee extract, sesame oil, perilla oil, kokahi (Ezokogi) extract, rice extract, Saishin extract, hawthorn extract , Sampens (Karaoketsumei) extract, Peony extract, Shirayuri extract, Mulberry (Sohakuhaku) extract, Touki extract, Beech extract, Blackcurrant extract, Hop extract, Maikaika (Makai, Hamanas)
Extract, mocca (blurred) extract, saxifrage extract, tea extract (such as oolong tea, black tea, and green tea), soybean extract, molasses extract, and arhat extract.
【0015】これらの美白剤のうち、特に好ましいもの
としては、ビタミンC及びその誘導体、カンゾウ抽出
物、ハトムギ(ヨクイニン)抽出物、コムギ抽出物、ビ
ャクレン抽出物、海藻抽出物、茶抽出物が挙げられる。Among these whitening agents, particularly preferred are vitamin C and its derivatives, licorice extract, barley (Yokuinin) extract, wheat extract, syrup extract, seaweed extract and tea extract. Can be
【0016】(抗酸化剤)また抗酸化剤としては、ビタ
ミンEおよびその誘導体(dl−α(β、γ)−トコフ
ェロール、酢酸dl−α−トコフェロール、ニコチン酸
−dl−α−トコフェロール、リノール酸−dl−α−
トコフェロール、コハク酸dl−α−トコフェロール等
のトコフェロール及びその誘導体、ユビキノン類等)、
ビタミンA及びその誘導体(パルミチン酸レチノール、
酢酸レチノール等のレチノール及びその誘導体、デヒド
ロレチナール等のレチナール及びその誘導体等)、カロ
チノイド(カロチン、リコピン、アスタキサンチン
等)、ビタミンB及びその誘導体(チアミン塩酸塩、チ
アミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸
ピリドキシン、ピリドキシンジオクタノエート、フラビ
ンアデニンヌクレオチド、シアノコバラミン、葉酸類、
ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸
類、コリン類等)、ビタミンC及びその誘導体(L−ア
スコルビン酸リン酸エステル、L−アスコルビン酸硫酸
エステル、ジパルミチン酸L−アスコルビル、テトライ
ソパルミチン酸L−アスコルビル等)、ビタミンD及び
その誘導体(エルゴカルシフェロール、コレカルシフェ
ロール、ジヒドロキシスタナール等)、ジブチルヒドロ
キシトルエン、ブチルヒドロキシアニソール、ルチン及
びその誘導体、チオタウリン、タウリン、ハイドロキノ
ン及びその誘導体、ヒスチジン、カテキン及びその誘導
体、グラブリジン、グラブレン、リクイリチン、イソリ
クイリチン及びこれらを含有するカンゾウ抽出物、グル
タチオン及びその誘導体、没食子酸及びその誘導体、キ
ュウリ抽出物、ケイケットウ抽出物、ゲンチアナ(リン
ドウ)抽出物、ゲンノショウコ抽出物、コレステロール
及びその誘導体、サンザシ抽出物、シャクヤク抽出物、
スーパーオキサイドディスムターゼ、イチョウ抽出物、
コガネバナ(オウゴン)抽出物、ニンジン抽出物、マイ
カイカ(マイカイ、ハマナス)抽出物、サンペンズ(カ
ワラケツメイ)抽出物、トルメンチラ抽出物、パセリ抽
出物、ブドウ抽出物、ボタン(ボタンピ)抽出物、マン
ニトール、メリッサ抽出物、ヤシャジツ(ヤシャ)抽出
物、ユキノシタ抽出物、ローズマリー(マンネンロウ)
抽出物、レタス抽出物、茶抽出物(烏龍茶、紅茶、緑茶
等)、微生物醗酵代謝産物、海藻抽出物、卵殻膜抽出
物、胎盤抽出物、羅漢果抽出物等が挙げられる。(Antioxidants) As antioxidants, vitamin E and its derivatives (dl-α (β, γ) -tocopherol, dl-α-tocopherol acetate, nicotinic acid-dl-α-tocopherol, linoleic acid) -Dl-α-
Tocopherols, tocopherols such as dl-α-tocopherol succinate and derivatives thereof, ubiquinones and the like),
Vitamin A and its derivatives (retinol palmitate,
Retinol such as retinol acetate and its derivatives, retinal such as dehydroretinal and its derivatives, etc., carotenoids (carotene, lycopene, astaxanthin, etc.), vitamin B and its derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, hydrochloride) Pyridoxine, pyridoxine dioctanoate, flavin adenine nucleotide, cyanocobalamin, folate,
Nicotinic acids such as nicotinic acid amide and benzyl nicotinate, cholines, etc., vitamin C and its derivatives (L-ascorbic acid phosphate, L-ascorbic acid sulfate, L-ascorbyl dipalmitate, L-tetraisopalmitate) -Ascorbyl, etc.), vitamin D and its derivatives (ergocalciferol, cholecalciferol, dihydroxystannal, etc.), dibutylhydroxytoluene, butylhydroxyanisole, rutin and its derivatives, thiotaurine, taurine, hydroquinone and its derivatives, histidine, catechin And its derivatives, glabridine, glabrene, liquiritin, isoliquiritin and liquorice extract containing them, glutathione and its derivatives, gallic acid and its derivatives, cucumber extract, Duel extract, gentian (Gentiana) extract, Geranium thunbergii extract, cholesterol and its derivatives, hawthorn extract, peony extract,
Superoxide dismutase, ginkgo extract,
Aspergillus oryzae extract, carrot extract, maikaika (maikai, hamanas) extract, sampens (kawaragetsumei) extract, tormentilla extract, parsley extract, grape extract, button (buttonpig) extract, mannitol, melissa extract Stuff, yasajitsu (yasa) extract, saxifrage extract, rosemary (mannenrou)
Extracts, lettuce extracts, tea extracts (such as oolong tea, black tea, and green tea), microbial fermentation metabolites, seaweed extracts, eggshell membrane extracts, placenta extracts, and arhat extract.
【0017】これらの抗酸化剤のうち、特に好ましいも
のとしては、ビタミンE及びその誘導体、ビタミンC及
びその誘導体、ルチン及びその誘導体、ヤシャジツ抽出
物、ユキノシタ抽出物、マイカイカ抽出物、スーパーオ
キサイドディスムターゼ、イチョウ抽出物、グルタチオ
ン、ヒスチジン、マンニトール、カロチノイドが挙げら
れる。Of these antioxidants, particularly preferred are vitamin E and its derivatives, vitamin C and its derivatives, rutin and its derivatives, yasazitsu extract, saxifrage extract, squid extract, superoxide dismutase, Ginkgo biloba extract, glutathione, histidine, mannitol, carotenoids.
【0018】(抗炎症剤)抗炎症剤としては、グリチル
リチン酸及びその誘導体、グリチルレチン酸及びその誘
導体、ビタミンB及びその誘導体(チアミン塩酸塩、チ
アミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸
ピリドキシン、ピリドキシンジオクタノエート、フラビ
ンアデニンヌクレオチド、シアノコバラミン、葉酸類、
ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸
類、コリン類等)、アロエ抽出物、アシタバ抽出物、ア
ルテア抽出物、アルニカ抽出物、イオウ及びその誘導
体、イラクサ抽出物、インチンコウ(カワラヨモギ)抽
出物、ウコン抽出物、キハダ(オウバク)抽出物、オト
ギリソウ抽出物、カミツレ抽出物、コンフリー(ヒレハ
リソウ)抽出物、スイカズラ(キンギンカ)抽出物、ク
レソン抽出物、サルビア(セージ)抽出物、ワレモコウ
(ジユ)抽出物、シコン(ムラサキ)抽出物、シソ抽出
物、シラカバ抽出物、ニワトコ抽出物、ガマ(ホオウ)
抽出物、ムクロジ抽出物、ユーカリ抽出物、ヨモギ抽出
物、レンゲソウ抽出物、コンドロイチン硫酸及びその誘
導体、酸化亜鉛等が挙げられる。(Anti-inflammatory agent) Examples of anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, vitamin B and its derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dihydrochloride). Octanoate, flavin adenine nucleotide, cyanocobalamin, folate,
Nicotinic acid amides, nicotinic acids such as benzyl nicotinate, cholines, etc.), aloe extract, ashitaba extract, altea extract, arnica extract, sulfur and its derivatives, nettle extract, cinnamon extract (turdworm), turmeric Extract, yellowfin (Otaku) extract, Hypericum perforatum extract, chamomile extract, Comfrey (Hypericum perforatum) extract, honeysuckle (Kinginka) extract, watercress extract, salvia (sage) extract, Waremokou (Jiyu) extract , Shikon (Murasaki) extract, Perilla extract, Birch extract, Elderberry extract, Gama (Houra)
Extracts, mud mushroom extracts, eucalyptus extracts, mugwort extracts, astragalus extracts, chondroitin sulfate and its derivatives, zinc oxide and the like.
【0019】これらの抗炎症剤のうち、特に好ましいも
のとしては、グリチルリチン酸及びその誘導体、グリチ
ルレチン酸及びその誘導体、ビタミンB類及びそれらの
誘導体、アルニカ抽出物、イラクサ抽出物、キハダ(オ
ウバク)抽出物、カミツレ抽出物、シソ抽出物、コンフ
リー(ヒレハリソウ)抽出物が挙げられる。Among these anti-inflammatory agents, particularly preferred are glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, vitamins B and their derivatives, arnica extract, nettle extract, and yellowfin (oubak) extract. And chamomile extract, perilla extract, and comfrey (Hypericum) extract.
【0020】(細胞賦活剤)細胞賦活剤としては、ビタ
ミンA及びその誘導体(パルミチン酸レチノール、酢酸
レチノール等のレチノール及びその誘導体、デヒドロレ
チナール等のレチナール及びその誘導体等)、カロチノ
イド(カロチン、リコピン、アスタキサンチン等)、ビ
タミンB及びその誘導体(チアミン塩酸塩、チアミン硫
酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキ
シン、ピリドキシンジオクタノエート、フラビンアデニ
ンヌクレオチド、シアノコバラミン、葉酸類、ニコチン
酸アミド、ニコチン酸ベンジル等のニコチン酸類、コリ
ン類等)、ビタミンC及びその誘導体(L−アスコルビ
ン酸リン酸エステル、L−アスコルビン酸硫酸エステ
ル、ジパルミチン酸L−アスコルビル、テトライソパル
ミチン酸L−アスコルビル等)、リボ核酸及びその塩、
デオキシリボ核酸及びその塩、α−及びγ−リノレン
酸、キサンチン及びその誘導体(カフェイン等)、アー
モンド抽出物、アスパラガス抽出物、アミノ酸及びその
誘導体(セリン、グルタミン酸、テアニン、ヒドロキシ
プロリン、ピロリドンカルボン酸等)、アンズ(キョウ
ニン)抽出物、イチョウ抽出物、ドコサヘキサエン酸及
びその誘導体、エイコサペンタエン酸及びその誘導体、
キハダ(オウバク)抽出物、オオムギ(バクガ)抽出
物、キウイ抽出物、キュウリ抽出物、乳酸、クエン酸、
コハク酸、シイタケ抽出物、スギナ抽出物、センブリ抽
出物、大豆抽出物、ナツメ(タイソウ)抽出物、ツボク
サ抽出物、トウガラシ抽出物、トウキンセンカ抽出物、
トマト抽出物、ニンニク抽出物、ニンジン抽出物、ヒノ
キチオール、ブクリョウ抽出物、ブドウ種子油、ブナ抽
出物、モモ抽出物、ユーカリ抽出物、ユリ抽出物、レタ
ス抽出物、レモン抽出物、ローズマリー(マンネンロ
ウ)抽出物、動物由来抽出物(イカスミ等軟体動物抽出
物、貝殻抽出物、貝肉抽出物、魚肉抽出物、鶏冠抽出
物、シルクプロテイン及びその分解物、胎盤抽出物、血
清除蛋白抽出物、ローヤルゼリー、ラクトフェリン又は
その分解物等)、微生物醗酵代謝産物(乳酸菌、ビフィ
ズス菌等由来)、霊芝抽出物等が挙げられる。(Cell activator) Cell activators include vitamin A and its derivatives (retinol and derivatives thereof such as retinol palmitate and retinol acetate, retinal and derivatives thereof such as dehydroretinal and the like), carotenoids (carotene, lycopene, and the like). Vitamin B and its derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, flavin adenine nucleotide, cyanocobalamin, folic acids, nicotinamide, benzyl nicotinate, etc.) Nicotinic acid, choline, etc.), vitamin C and its derivatives (L-ascorbic acid phosphate, L-ascorbic acid sulfate, L-ascorbyl dipalmitate, L-ascolate tetraisopalmitate) Buildings), ribonucleic acids and salts thereof,
Deoxyribonucleic acid and its salts, α- and γ-linolenic acid, xanthine and its derivatives (such as caffeine), almond extract, asparagus extract, amino acids and its derivatives (serine, glutamic acid, theanine, hydroxyproline, pyrrolidone carboxylic acid) Etc.), apricot (kyonin) extract, ginkgo extract, docosahexaenoic acid and its derivatives, eicosapentaenoic acid and its derivatives,
Yellowfin (Obak) extract, Barley (Bakuga) extract, Kiwi extract, Cucumber extract, Lactic acid, Citric acid,
Succinic acid, shiitake extract, horse chestnut extract, assembly extract, soybean extract, jujube (traditional) extract, camellia extract, capsicum extract, calendula extract,
Tomato extract, garlic extract, carrot extract, hinokitiol, bukuro extract, grape seed oil, beech extract, peach extract, eucalyptus extract, lily extract, lettuce extract, lemon extract, rosemary (mannen wax ) Extracts, animal-derived extracts (mollusc extracts such as cuttlefish, shell extract, shellfish extract, fish extract, cockscomb extract, silk protein and its degradation products, placenta extract, serum deproteinized extract, Royal jelly, lactoferrin or a degradation product thereof), microbial fermentation metabolites (derived from lactic acid bacteria, bifidobacteria, etc.), reishi extract, and the like.
【0021】これらの細胞賦活剤のうち、特に好ましい
ものとしては、ビタミンA及びその誘導体、ビタミンC
及びその誘導体、クエン酸、リンゴ酸、ピロリドンカル
ボン酸、鶏冠抽出物、酵母抽出物、乳酸菌抽出物、ビフ
ィズス菌抽出物、霊芝抽出物などの微生物由来の抽出物
あるいは発酵代謝産物から選ばれる微生物由来の抽出
物、ニンジン抽出物、大豆抽出物、オオムギ(バクガ)
抽出物が挙げられる。Of these cell activators, particularly preferred are vitamin A and its derivatives, vitamin C
And its derivatives, citric acid, malic acid, pyrrolidone carboxylic acid, cockscomb extract, yeast extract, lactic acid bacteria extract, bifidobacterium extract, microorganisms selected from fermented metabolites, such as extracts derived from microorganisms such as Lingzhi extract Origin Extract, Carrot Extract, Soy Extract, Barley (Bakuga)
Extract.
【0022】(紫外線防止剤)紫外線防止剤としては、
パラメトキシケイ皮酸−2−エチルヘキシル、4−te
rt−ブチル−4’−メトキシジベンゾイルメタン、2
−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒド
ロキシ−4−メトキシベンゾフェノン−5−スルホン
酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5
−スルホン酸ナトリウム、2−ヒドロキシ−4−メトキ
シベンゾフェノン−5−硫酸ナトリウム、酸化チタン、
酸化亜鉛等が挙げられる。また、粉体は微粒子のものを
用いるとより高い効果が発揮される。(Ultraviolet inhibitor) As the ultraviolet inhibitor,
2-ethylhexyl paramethoxycinnamate, 4-te
rt-butyl-4'-methoxydibenzoylmethane, 2
-Hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, 2-hydroxy-4-methoxybenzophenone-5
Sodium sulfonate, 2-hydroxy-4-methoxybenzophenone-5-sodium sulfate, titanium oxide,
Zinc oxide and the like can be mentioned. In addition, a higher effect is exhibited when fine particles are used.
【0023】これらの紫外線防止剤のうち、特に好まし
いものとしては、パラメトキシケイ皮酸−2−エチルヘ
キシル、4−tert−ブチル−4’−メトキシジベン
ゾイルメタン、2−ヒドロキシ−4−メトキシベンゾフ
ェノン、酸化チタン、微粒子酸化チタン、酸化亜鉛等が
挙げられる。Of these UV inhibitors, particularly preferred are 2-ethylhexyl paramethoxycinnamate, 4-tert-butyl-4'-methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, Examples include titanium oxide, fine particle titanium oxide, and zinc oxide.
【0024】本発明の皮膚外用剤における上記成分
(B)の薬効剤の配合量は、薬効剤の種類により相違す
るが、以下に示す範囲とすることが好ましい。この範囲
であれば、成分(A)のクランベリー果実搾汁液及び/
又はクランベリー果実抽出物と組み合わせた場合、製剤
及び製剤中の成分(A)成分のクランベリー果実搾汁液
及び/又はクランベリー果実抽出物の経時安定性に影響
を及ぼすことがなく、より高い美白効果および美肌効果
を発揮させることがで)きる。The compounding amount of the above-mentioned component (B) in the external preparation for skin of the present invention varies depending on the kind of the above-mentioned medicinal agent, but is preferably in the following range. Within this range, the cranberry fruit juice of component (A) and / or
Or, when combined with the cranberry fruit extract, it does not affect the stability over time of the cranberry fruit juice and / or the cranberry fruit extract of the preparation and the component (A) in the preparation, so that a higher whitening effect and skin beauty can be obtained. Can be effective).
【0025】すなわち、本発明の皮膚外用剤における美
白剤の配合量は、好ましくは0.00001〜5%であ
り、より好ましくは0.0001〜3%の範囲である。
胎盤抽出物及び植物抽出物を抽出液のまま用いる場合は
乾燥固形分としてこの範囲であれば良い。この範囲であ
ればより優れた美白、美肌効果を示し、かつ、使用感の
良好な皮膚外用剤が得られる。That is, the amount of the whitening agent in the external preparation for skin of the present invention is preferably 0.00001 to 5%, more preferably 0.0001 to 3%.
When the placenta extract and the plant extract are used as they are, the dry solid content may be within this range. Within this range, a skin external preparation exhibiting more excellent whitening and skin effect and having a good feeling upon use can be obtained.
【0026】本発明の皮膚外用剤における抗酸化剤の配
合量は、好ましくは0.00001〜5%、より好まし
くは0.0001〜3%の範囲である。植物抽出物を抽
出液のまま用いる場合は乾燥固形分としてこの範囲であ
れば良い。この範囲であればより優れた抗酸化効果の発
現がみられ、かつ、優れた美白、美肌効果を示す皮膚外
用剤が得られる。The content of the antioxidant in the external preparation for skin of the present invention is preferably 0.00001 to 5%, more preferably 0.0001 to 3%. When the plant extract is used as it is as the extract, the dry solid content may be within this range. Within this range, a skin external preparation exhibiting more excellent antioxidant effect and exhibiting excellent whitening and beautiful skin effects can be obtained.
【0027】本発明の皮膚外用剤における抗炎症剤の配
合量としては、0.00001〜5%の範囲が好まし
く、より好ましくは0.0001〜3%の範囲である。
植物抽出物を抽出液のまま用いる場合は乾燥固形分とし
てこの範囲であれば良い。この範囲であれば優れた抗炎
症効果がみられ、かつ、優れた美白、美肌効果を示す皮
膚外用剤が得られる。The compounding amount of the anti-inflammatory agent in the external preparation for skin of the present invention is preferably in the range of 0.00001 to 5%, more preferably in the range of 0.0001 to 3%.
When the plant extract is used as it is as the extract, the dry solid content may be within this range. Within this range, an external preparation for skin which exhibits an excellent anti-inflammatory effect and also has excellent whitening and skin beautiful effects can be obtained.
【0028】本発明の皮膚外用剤における細胞賦活剤の
配合量としては、好ましくは0.00001〜5%、よ
り好ましくは0.0001〜3%の範囲である。抽出物
を抽出液のまま用いる場合は、乾燥固形分としてこの範
囲であれば良い。この範囲であればより優れた肌荒れ改
善効果が発現し、かつ、優れた美白、美肌効果を示す皮
膚外用剤が得られる。The amount of the cell activator in the external preparation for skin of the present invention is preferably 0.00001 to 5%, more preferably 0.0001 to 3%. When the extract is used as it is, the extract may be in this range as a dry solid content. Within this range, a skin external preparation that exhibits a more excellent effect of improving skin roughness and that exhibits excellent whitening and skin effect can be obtained.
【0029】本発明の皮膚外用剤における紫外線防止剤
の配合量としては、好ましくは0.01〜30%、より
好ましくは0.1〜20%の範囲である。この範囲であ
ればより優れた紫外線防止効果が発現し、かつ、優れた
美白、美肌効果を示す皮膚外用剤が得られる。The compounding amount of the ultraviolet ray inhibitor in the external preparation for skin of the present invention is preferably 0.01 to 30%, more preferably 0.1 to 20%. Within this range, a skin external preparation that exhibits a more excellent ultraviolet ray preventing effect and also has an excellent whitening and skin beautiful effect can be obtained.
【0030】これらの美白剤、抗酸化剤、抗炎症剤、細
胞賦活剤及び紫外線防止剤は、一種又は二種以上組み合
わせて用いることができる。These whitening agents, antioxidants, anti-inflammatory agents, cell activators and UV inhibitors can be used alone or in combination of two or more.
【0031】上記の成分(A)と成分(B)を組み合せ
た皮膚外用剤も、常法に従い、必須成分である成分
(A)と成分(B)とを通常の皮膚外用剤として知られ
る種々の形態の基剤に配合して調製することができる。The external preparation for skin which combines the above-mentioned components (A) and (B) is also prepared according to a conventional method using the essential components (A) and (B) as various conventional external preparations for skin. Can be prepared by blending with a base of the form:
【0032】皮膚外用剤の配合形態の例としては、特に
限定されず、例えば、乳液、クリーム、化粧水、美容
液、パウダー、パック、洗浄料、メーキャップ化粧料、
分散液、軟膏などの化粧料や外用医薬品等とすることが
できる。Examples of the form of the external preparation for skin are not particularly limited, and include, for example, milky lotions, creams, lotions, essences, powders, packs, detergents, makeup cosmetics,
It can be a cosmetic such as a dispersion or an ointment, or an external medicine.
【0033】また、本発明の皮膚外用剤には、上記必須
成分の他、必要に応じて本発明の効果を損なわない範囲
で、通常、化粧料や医薬部外品、外用医薬品等の製剤に
使用される成分、すなわち、水(精製水、温泉水、深層
水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、
粉体、アルコール類、水溶性高分子、皮膜形成剤、樹
脂、包接化合物、塩類、PH調整剤、キレート剤、清涼
剤、動物・微生物由来の抽出物、植物抽出物、抗菌剤、
保湿剤、血行促進剤、酵素、収斂剤、抗脂漏剤、角質溶
解剤、ホルモン類、ビタミン類、防腐剤、香料等を加え
ることができる。好適な成分の具体例としてはそれぞれ
以下に示すもの等が挙げられる。ここで、「誘導体」に
は形成可能な塩が含まれる。In addition to the above-mentioned essential components, the external preparation for skin of the present invention is usually used in the preparation of cosmetics, quasi-drugs, and external medicines, as long as the effects of the present invention are not impaired. Ingredients used, i.e., water (purified water, hot spring water, deep water, etc.), oil agent, surfactant, metal soap, gelling agent,
Powders, alcohols, water-soluble polymers, film-forming agents, resins, clathrates, salts, PH regulators, chelating agents, cooling agents, extracts from animals and microorganisms, plant extracts, antibacterial agents,
Moisturizing agents, blood circulation promoters, enzymes, astringents, antiseborrheic agents, keratolytic agents, hormones, vitamins, preservatives, fragrances and the like can be added. Specific examples of suitable components include those shown below. Here, the “derivative” includes a salt that can be formed.
【0034】油剤としては、基剤の構成成分又は使用
性、使用感を良くし、通常の皮膚外用剤に使用されるも
のであれば、固形、半固形、液体であるか、揮発性であ
るか等の性状や、動物油、植物油、鉱物油等の天然系油
であるか、合成油であるか等を問わず、炭化水素類、油
脂類、ロウ類、硬化油類、エステル類、脂肪酸類、高級
アルコール類、シリコーン油類、フッ素系油類、親油性
界面活性剤等を使用することができる。具体的には、パ
ラフィンワックス、セレシンワックス、マイクロクリス
タリンワックス、カルナウバワックス、キャンデリラワ
ックス、ミツロウ、モクロウ、ゲイロウ、ポリエチレン
ワックス、流動パラフィン、スクワラン、ポリブテン、
ワセリン、オリーブ油、ヒマシ油、ホホバ油、マカデミ
アンナッツ油、ラノリン、ロジン酸ペンタエリトリット
エステル、ジペンタエリトリット脂肪酸エステル、コレ
ステロール脂肪酸エステル、N−ラウロイル−L−グル
タミン酸ジ(コレステリル・ベヘニル・オクチルドデシ
ル)、ミリスチン酸イソプロピル、パルミチン酸イソプ
ロピル、2−エチルヘキサン酸セチル、ミリスチン酸オ
クチルドデシル、トリオクタン酸グリセリル、ジイソス
テアリン酸ポリグリセリル、トリイソステアリン酸ポリ
グリセリル、ステアリン酸、ラウリン酸、ミリスチン
酸、ベへニン酸、イソステアリン酸、オレイン酸、セチ
ルアルコール、ステアリルアルコール、ラウリルアルコ
ール、イソステアリルアルコール、オレイルアルコー
ル、ジメチルポリシロキサン、メチルフェニルポリシロ
キサン、メチルハイドロジェンポリシロキサン、架橋型
メチルポリシロキサン、架橋型メチルフェニルポリシロ
キサン等のシリコーン油剤、パーフルオロオクタン、パ
ーフルオロデカン、パーフルオロポリエーテル、フッ素
変性シリコーン等のフッ素系油剤等が挙げられる。[0034] The oils are solid, semi-solid, liquid or volatile as long as they are constituents of the base or improve the usability and usability, and are used in ordinary skin external preparations. Whether they are natural oils such as animal oils, vegetable oils, mineral oils, or synthetic oils, hydrocarbons, oils and fats, waxes, hardened oils, esters, and fatty acids And higher alcohols, silicone oils, fluorinated oils, and lipophilic surfactants. Specifically, paraffin wax, ceresin wax, microcrystalline wax, carnauba wax, candelilla wax, beeswax, mokuro, gay wax, polyethylene wax, liquid paraffin, squalane, polybutene,
Vaseline, olive oil, castor oil, jojoba oil, macadamian nut oil, lanolin, pentaerythritol rosinate, dipentaerythritol fatty acid ester, cholesterol fatty acid ester, di-N-lauroyl-L-glutamate (cholesteryl behenyl octyldodecyl) ), Isopropyl myristate, isopropyl palmitate, cetyl 2-ethylhexanoate, octyldodecyl myristate, glyceryl trioctanoate, polyglyceryl triisostearate, polyglyceryl triisostearate, stearic acid, lauric acid, myristic acid, behenic acid, isostearin Acid, oleic acid, cetyl alcohol, stearyl alcohol, lauryl alcohol, isostearyl alcohol, oleyl alcohol, dimethylpolysilo Sun, methylphenylpolysiloxane, methylhydrogenpolysiloxane, crosslinked methylpolysiloxane, silicone oil such as crosslinked methylphenylpolysiloxane, perfluorooctane, perfluorodecane, perfluoropolyether, fluorine-based silicone, etc. Oils and the like.
【0035】界面活性剤は、油剤等の乳化や可溶化等の
ために用いられ、アニオン性、カチオン性、両性及び非
イオン性の活性剤を用いることができる。例えば、アニ
オン界面活性剤としては、ステアリン酸、ラウリン酸の
ような脂肪酸及びそれらの無機及び有機塩、アルキルベ
ンゼン硫酸塩、アルキルスルホン酸塩、α−オレフィン
スルホン酸塩、ジアルキルスルホコハク酸塩、α−スル
ホン化脂肪酸塩、アシルメチルタウリン塩、N−メチル
−N−アルキルタウリン塩、ポリオキシエチレンアルキ
ルエーテル硫酸塩、ポリオキシエチレンアルキルフェニ
ルエーテル硫酸塩、アルキル燐酸塩、ポリオキシエチレ
ンアルキルエーテル燐酸塩、ポリオキシエチレンアルキ
ルフェニルエーテル燐酸塩、N−アシルアミノ酸塩、N
−アシル−N−アルキルアミノ酸塩、ο−アルキル置換
リンゴ酸塩、アルキルスルホコハク酸塩等が挙げられ
る。両性界面活性剤としては、アミノ酸タイプやベタイ
ンタイプのカルボン酸型、硫酸エステル型、スルホン酸
型、リン酸エステル型のものがあり、人体に対して安全
とされるものが使用できる。例えば、N,N−ジメチル
−N−アルキル−N−カルボキシルメチルアンモニウム
ベタイン、N,N−ジアルキルアミノアルキレンカルボ
ン酸、N,N,N−トリアルキル−N−スルフォアルキ
レンアンモニウムベタイン、N,N−ジアルキル−N,
N−ビス(ポリオキシエチレン硫酸)アンモニウムベタ
イン、2−アルキル−1−ヒドロキシエチル−1−カル
ボキシメチルイミダゾリニウムベタイン等が挙げられ
る。非イオン界面活性剤としては、グリセリン脂肪酸エ
ステル及びそのアルキレングリコール付加物、ポリグリ
セリン脂肪酸エステル及びそのアルキレングリコール付
加物、プロピレングリコール脂肪酸エステル及びそのア
ルキレングリコール付加物、ソルビタン脂肪酸エステル
及びそのアルキレングリコール付加物、ソルビトールの
脂肪酸エステル及びそのアルキレングリコール付加物、
ポリアルキレングリコール脂肪酸エステル、ショ糖脂肪
酸エステル、グリセリンアルキルエーテル、ポリオキシ
アルキレンアルキルエーテル、ポリオキシエチレンアル
キルフェニルエーテル、ポリオキシエチレン硬化ヒマシ
油、ラノリンのアルキレングリコール付加物等が挙げら
れる。Surfactants are used for emulsification and solubilization of oils and the like, and anionic, cationic, amphoteric and nonionic surfactants can be used. For example, anionic surfactants include fatty acids such as stearic acid and lauric acid and their inorganic and organic salts, alkylbenzene sulfates, alkyl sulfonates, α-olefin sulfonates, dialkyl sulfosuccinates, α-sulfones Fatty acid salt, acylmethyl taurine salt, N-methyl-N-alkyl taurine salt, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl ether sulfate, alkyl phosphate, polyoxyethylene alkyl ether phosphate, polyoxy Ethylene alkyl phenyl ether phosphate, N-acyl amino acid salt, N
-Acyl-N-alkylamino acid salts, o-alkyl-substituted malates, alkylsulfosuccinates and the like. As the amphoteric surfactant, there are carboxylic acid type, sulfate type, sulfonic acid type and phosphate type of amino acid type and betaine type, and those which are safe for human body can be used. For example, N, N-dimethyl-N-alkyl-N-carboxylmethylammonium betaine, N, N-dialkylaminoalkylenecarboxylic acid, N, N, N-trialkyl-N-sulfoalkyleneammonium betaine, N, N- Dialkyl-N,
N-bis (polyoxyethylene sulfate) ammonium betaine, 2-alkyl-1-hydroxyethyl-1-carboxymethylimidazolinium betaine, and the like. As the nonionic surfactant, glycerin fatty acid ester and its alkylene glycol adduct, polyglycerin fatty acid ester and its alkylene glycol adduct, propylene glycol fatty acid ester and its alkylene glycol adduct, sorbitan fatty acid ester and its alkylene glycol adduct, Fatty acid esters of sorbitol and alkylene glycol adducts thereof,
Polyalkylene glycol fatty acid ester, sucrose fatty acid ester, glycerin alkyl ether, polyoxyalkylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene hydrogenated castor oil, alkylene glycol adduct of lanolin and the like can be mentioned.
【0036】金属セッケンとしては、脂肪酸等のアルカ
リ塩以外の金属塩であり、ステアリン酸アルミニウム、
ステアリン酸マグネシウム、ラウリン酸亜鉛等が挙げら
れる。The metal soap is a metal salt other than an alkali salt such as a fatty acid, such as aluminum stearate,
Examples include magnesium stearate and zinc laurate.
【0037】ゲル化剤は、系の安定化や使用性、使用感
を良くするために用いられ、N−ラウロイル−L−グル
タミン酸等のアミノ酸誘導体、デキストリンパルミチン
酸エステル等のデキストリン脂肪酸エステル、ショ糖脂
肪酸エステル、有機変性粘土鉱物等が挙げられる。The gelling agent is used for stabilizing the system, improving the usability, and the feeling upon use. Amino acid derivatives such as N-lauroyl-L-glutamic acid; dextrin fatty acid esters such as dextrin palmitic acid ester; Examples include fatty acid esters and organically modified clay minerals.
【0038】粉体は、主として着色や皮膚の隠蔽、又は
使用感を良くするため等多目的に用いられ、通常の化粧
料に使用されるものであれば、その形状(球状、針状、
板状、等)や粒子径(煙霧状、微粒子、顔料級等)、粒
子構造(多孔質、無孔質等)を問わず、いずれのものも
使用することができる。例えば、無機粉体としては、硫
酸バリウム、炭酸カルシウム、タルク、雲母、合成雲
母、マイカ、カオリン、セリサイト、ケイ酸、無水ケイ
酸、ケイ酸アルミニウムマグネシウム、セラミックスパ
ウダー、窒化ホウ素等が挙げられ、有機粉体としては、
ポリエステルパウダー、ポリエチレンパウダー、ポリス
チレンパウダー、ナイロンパウダー、ラウロイルリジン
等が挙げられ、有色顔料としては、酸化鉄、カーボンブ
ラック、酸化クロム、紺青、群青等の無機系顔料、ター
ル系色素をレーキ化したもの、天然色素をレーキ化した
ものが挙げられ、パール顔料としては、酸化チタン被覆
雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸
化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タル
ク、魚鱗箔、酸化チタン被覆着色雲母等、その他タール
色素、カルミン酸等の天然色素等が挙げられる。これら
の粉体を複合化したり、油剤やシリコーン、又はフッ素
化合物等で表面処理を行なっても良い。The powder is used for various purposes such as coloring, concealing the skin, or improving the feeling of use. If the powder is used in ordinary cosmetics, its shape (spherical, needle-like,
Any of them can be used regardless of plate shape, etc., particle size (fog, fine particles, pigment grade, etc.) and particle structure (porous, non-porous, etc.). For example, examples of the inorganic powder include barium sulfate, calcium carbonate, talc, mica, synthetic mica, mica, kaolin, sericite, silicic acid, silicic anhydride, aluminum magnesium silicate, ceramic powder, and boron nitride. As organic powder,
Polyester powder, polyethylene powder, polystyrene powder, nylon powder, lauroyl lysine, and the like.Examples of colored pigments include iron oxides, carbon black, chromium oxide, navy blue, ultramarine blue and other inorganic pigments, and tar pigments. Pearl pigments include titanium oxide coated mica, titanium oxide coated mica, bismuth oxychloride, titanium oxide coated bismuth oxychloride, titanium oxide coated talc, fish scale foil, titanium oxide coated coloring Examples include mica and the like, and other tar dyes and natural dyes such as carminic acid. These powders may be compounded, or may be surface-treated with an oil agent, silicone, a fluorine compound, or the like.
【0039】アルコール類や水溶性高分子は、系の安定
化や使用性、使用感を良くするために用いられ、又、保
湿効果を得るためにも用いられる。アルコール類として
は、エタノール、イソプロパノール等の低級アルコー
ル、グリセリン、ジグリセリン、ポリグリセリン等のグ
リセロール類、エチレングリコール、ジエチレングリコ
ール、トリエチレングリコール、プロピレングリコー
ル、ジプロピレングリコ−ル、1,3−ブチレングリコ
ール、ポリエチレングリコール等のグリコール類等が挙
げられる。[0039] Alcohols and water-soluble polymers are used for stabilizing the system, improving usability and feeling of use, and also for obtaining a moisturizing effect. As alcohols, lower alcohols such as ethanol and isopropanol, glycerols such as glycerin, diglycerin and polyglycerin, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, And glycols such as polyethylene glycol.
【0040】水溶性高分子としては、カラギーナン、ペ
クチン、寒天、ローカストビーンガム、グアーガム等の
植物系高分子、キサンタンガム等の微生物系高分子、カ
ゼイン、ゼラチン等の動物系高分子、デンプン等のデン
プン系高分子、メチルセルロース、エチルセルロース、
カルボキシメチルセルロース、ヒドロキシプロピルセル
ロース、ニトロセルロース、結晶セルロース等のセルロ
ース系高分子、アルギン酸ナトリウム等のアルギン酸系
高分子、カルボキシビニルポリマー等のビニル系高分
子、ポリオキシエチレン系高分子、ポリオキシエチレン
ポリオキシプロピレン共重合体系高分子、ポリアクリル
酸ナトリウム等のアクリル系高分子、ベントナイト、ヘ
クトライト等の無機系水溶性高分子等が挙げられる。ま
た、この中には、ポリビニルアルコールやポリビニルピ
ロリドン等の皮膜形成剤も含まれる。Examples of the water-soluble polymer include plant polymers such as carrageenan, pectin, agar, locust bean gum and guar gum, microbial polymers such as xanthan gum, animal polymers such as casein and gelatin, and starches such as starch. Polymer, methylcellulose, ethylcellulose,
Cellulosic polymers such as carboxymethylcellulose, hydroxypropylcellulose, nitrocellulose and crystalline cellulose; alginic acid polymers such as sodium alginate; vinyl polymers such as carboxyvinyl polymer; polyoxyethylene polymers; polyoxyethylene polyoxy Examples include propylene copolymer polymers, acrylic polymers such as sodium polyacrylate, and inorganic water-soluble polymers such as bentonite and hectorite. In addition, film-forming agents such as polyvinyl alcohol and polyvinyl pyrrolidone are also included in these.
【0041】動物または微生物由来抽出物としては、ヘ
モグロビン又はその分解物、イカスミ等の哺乳類、鳥
類、貝類、昆虫類、魚類、軟体動物類、甲殻類等の動物
由来の抽出物、微生物由来の抽出物等が挙げられる。動
物または微生物由来抽出物を配合することによって、保
湿効果、細胞賦活効果、美白効果、抗炎症効果、皮膚老
化防止効果、活性酸素除去効果、血行促進効果等を付与
することができる。Examples of extracts derived from animals or microorganisms include hemoglobin or its degradation products, extracts such as mammals such as cuttlefish, birds, shellfish, insects, fish, molluscs, and crustaceans, and extracts derived from microorganisms. Objects and the like. By blending an animal or microorganism-derived extract, a moisturizing effect, a cell activating effect, a whitening effect, an anti-inflammatory effect, a skin aging preventing effect, an active oxygen removing effect, a blood circulation promoting effect, and the like can be imparted.
【0042】植物抽出物としては、植物の抽出部位や、
抽出方法等に特に制限はなく、例えば植物の全草、又は
根、茎、幹、樹皮、幼芽、葉、花、果実、種子等から抽
出することが出来、これらを乾燥、細切、圧搾、或いは
発酵等、適宜処理を施し、種々の適当な溶媒を用いて低
温もしくは室温〜加温下で抽出することができる。抽出
溶媒としては、例えば水;メチルアルコール、エチルア
ルコール等の低級1価アルコール;グリセリン、プロピ
レングリコール、1,3−ブチレングリコール等の液状
多価アルコール等の1種または2種以上を用いることが
できる。また、ヘキサン、アセトン、酢酸エチル、エー
テル等の親油性溶媒を用いて抽出することもでき、その
他、スクワラン等の油性成分等により抽出したものでも
良い。得られた抽出液は濾過または吸着、脱色、精製し
て溶液状、ペースト状、ゲル状、粉末状とすることもで
きる。必要ならば、効果に影響のない範囲で更に、脱
臭、脱色等の精製処理をしても良い。植物としては、ア
マチャ、ウスベニアオイ、オドリコソウ、オノニス、カ
ラスムギ、クインスシード、クチナシ、クマザサ、グレ
ープフルーツ、ゴボウ、ゴマ、サボテン、サボンソウ、
ジオウ、シモツケ、ショウガ、ショウブ、セイヨウハッ
カ(ペパーミント)、ゼニアオイ(ウスベニタチアオ
イ)、センキュウ、タチジャコウソウ(タイム)、ハマ
メリス、バラ、ヒノキ、ヒマワリ、フキタンポポ、ブッ
チャーズブルーム、プルーン、ヘチマ、ボダイジュ、ホ
ホバ、マカデミアナッツ、オリーブ、サフラワー、ヒマ
ワリ、アボガド、メドゥホーム、ツバキ、ボラージ(ル
リジサ)、カカオ、シア、マツ、マルメロ、マロニエ、
ヤグルマソウ、ライム、ラベンダー、リンゴ等が挙げら
れる。植物抽出物を配合することによって、保湿効果、
細胞賦活効果、美白効果、抗炎症効果、皮膚老化防止効
果、活性酸素除去効果、血行促進効果等を付与すること
ができる。The plant extract includes a plant extraction site,
There is no particular limitation on the extraction method and the like. For example, it can be extracted from the whole plant, or the roots, stems, stems, barks, sprouts, leaves, flowers, fruits, seeds, etc., and dried, shredded, and squeezed. Alternatively, it can be subjected to an appropriate treatment such as fermentation or the like, and can be extracted at low temperature or at room temperature to heating using various appropriate solvents. As the extraction solvent, for example, one or more kinds of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol can be used. . Extraction can also be carried out using a lipophilic solvent such as hexane, acetone, ethyl acetate, ether, etc. Alternatively, extraction using an oily component such as squalane may be used. The resulting extract may be filtered, adsorbed, decolored, and purified to a solution, paste, gel, or powder. If necessary, purification treatment such as deodorization and decolorization may be performed within a range that does not affect the effect. Plants include: Amachea, Usbania oil, Odorikosou, Ononis, oats, quince seed, gardenia, kumazasa, grapefruit, burdock, sesame, cactus, sabonsou,
Jio, Shimotsuke, Ginger, Shobu, Common mint (Peppermint), Gentle oyster (Usubenitachioi), Senkyu, Tachijakosou (thyme), Hamamerisu, Rose, Hinoki, Sunflower, Fukidanpopo, Butchers bloom, Prune, Hojima, Bodaiju, Macadamia nuts, olives, safflower, sunflowers, avocados, medou homes, camellias, borage (rurizisa), cacao, shea, pine, quince, marronie,
Cornflower, lime, lavender, apple and the like. Moisturizing effect by blending plant extract,
Cell activating effect, whitening effect, anti-inflammatory effect, skin aging preventing effect, active oxygen removing effect, blood circulation promoting effect and the like can be provided.
【0043】抗菌剤は、パラクロルメタクレゾール、塩
化ベンザルコニウム、イソプロピルメチルフェノール等
が挙げられ、これらを配合することにより、ニキビなど
細菌性の皮膚の炎症による色素沈着を抑制し、さらに高
い美白、美肌効果を発揮することができる。Examples of the antibacterial agent include parachlorometacresol, benzalkonium chloride, and isopropylmethylphenol. When these are blended, pigmentation due to bacterial skin inflammation such as acne is suppressed, and higher whitening is achieved. , Can show beautiful skin effect.
【0044】保湿剤としては、コラーゲン、エラスチ
ン、ケラチン等のタンパク質またはそれらの誘導体、加
水分解物並びにそれらの塩、コンドロイチン硫酸、ヒア
ルロン酸等のムコ多糖及びその誘導体、セリン、グリシ
ン、テアニン、アスパラギン酸、アルギニン等のアミノ
酸及びそれらの誘導体、ソルビトール、マルチトール、
エリスリトール、トレハロース、イノシトール、グルコ
ース、キシリトール、蔗糖およびその誘導体、デキスト
リン及びその誘導体、ハチミツ等の糖類、D−パンテノ
ール及びその誘導体、糖脂質、セラミド、ピロリドンカ
ルボン酸及びその塩、大豆及び卵由来のリン脂質、尿素
等が挙げられる。これらの保湿剤を配合することによ
り、より高い美白、美肌効果を発揮し、透明感のある肌
を実現することができる。Examples of the humectant include proteins such as collagen, elastin and keratin or derivatives thereof, hydrolysates and salts thereof, mucopolysaccharides such as chondroitin sulfate and hyaluronic acid and derivatives thereof, serine, glycine, theanine and aspartic acid. , Amino acids such as arginine and their derivatives, sorbitol, maltitol,
Erythritol, trehalose, inositol, glucose, xylitol, sucrose and its derivatives, dextrin and its derivatives, saccharides such as honey, D-panthenol and its derivatives, glycolipids, ceramide, pyrrolidonecarboxylic acid and its salts, soybeans and eggs Phospholipids, urea and the like. By blending these humectants, higher whitening and skin beautiful effects can be exhibited, and transparent skin can be realized.
【0045】血行促進剤は、皮膚の血流をうながすこと
によってメラニンの排出を促進する目的で用いられ、ト
ウガラシチンキ、γ―オリザノール等が挙げられ、酵素
としてはリパーゼ、パパイン等が挙げられる。これらを
配合することにより、さらに高い美白、美肌効果が発揮
できる。The blood circulation promoting agent is used for promoting the excretion of melanin by promoting the blood flow of the skin, and includes, for example, pepper tincture, γ-oryzanol, and the like, and the enzymes include lipase, papain, and the like. By blending these, even higher whitening and beautiful skin effects can be exhibited.
【0046】[0046]
【実施例】次に参考例、試験例及び実施例を挙げて本発
明を更に詳細に説明するが、本発明はこれらになんら制
約されるものではない。EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples and Examples, but the present invention is not limited thereto.
【0047】参考例1 クランベリー果実搾汁液の製造 常法によりクランベリー果実を破砕、裏ごしして、種子
等を除去し、クランベリー果実搾汁液を得た。ついで、
摩砕機を用いこのクランベリー搾汁液を高速回転で数回
循環することにより、微細化処理を行った。得られた処
理液を遠心分離にかけ、遠心分離を行ない、大部分の不
溶性の固形分を含む沈殿物と、液体部(固形分7%)に
分離し、この液体部分を精密ろ過膜でろ過処理を行な
い、クランベリー果実搾汁液を得た。Reference Example 1 Production of Cranberry Fruit Juice Cranberry fruit was crushed and strained by a conventional method to remove seeds and the like to obtain a cranberry fruit juice. Then
The cranberry juice was circulated several times at high speed using a grinder to perform a fine treatment. The obtained processing solution is centrifuged and centrifuged to separate the sediment containing most insoluble solids and the liquid part (solid content 7%), and this liquid part is subjected to filtration treatment with a microfiltration membrane. Was carried out to obtain a cranberry fruit juice.
【0048】参考例2 クランベリー果実抽出物の製造 常法によりクランベリー果実10gを破砕し、50vo
l%1,3−ブチレングリコール溶液、及び50vol
%エチルアルコールの各100mLを加え、室温にて3
日間抽出を行ったのち濾過して各抽出物を得た。これら
抽出物の乾燥固形分はそれぞれ1.5%及び1.8%で
あった。Reference Example 2 Production of Cranberry Fruit Extract 10 g of cranberry fruit was crushed by a conventional method and
1% 1,3-butylene glycol solution, and 50 vol
100 mL of ethyl alcohol at room temperature.
After extraction for one day, filtration was performed to obtain each extract. The dry solids of these extracts were 1.5% and 1.8%, respectively.
【0049】参考例3 ヨクイニン抽出物の製造 ヨクイニン(日局)10gに、含水濃度70vol%エ
チルアルコール100mLを加え、室温にて3日間抽出を
行ったのち濾過してヨクイニン抽出物を得た。このとき
ヨクイニン抽出物の乾燥固形分は0.8%であった。Reference Example 3 Preparation of Yokuinin Extract To 10 g of Yokuinin (JP), 100 mL of 70 vol% ethyl alcohol was added, extracted at room temperature for 3 days, and filtered to obtain a Yokuinin extract. At this time, the dry solid content of the yokunin extract was 0.8%.
【0050】試験例1 細胞培養によるメラニン生成抑
制及び細胞生存率試験 マウス由来のB16メラノーマ培養細胞を使用した。2
枚の6穴シャーレに10%FBS含有MEM培地を適量
とり、B16メラノーマ細胞を播種し、37℃、二酸化
炭素濃度5%中にて静置した。翌日、参考例1で得たク
ランベリー果実搾汁液又はクランベリー果実抽出物を最
終濃度が固形分に換算して0(対照)、60、180、
600μg/mLとなるように検体調製液を添加し混和し
た。培養5日目に培地を交換し、再度検体調製液を添加
した。翌日、培地を除き、1枚のシャーレについて、細
胞をリン酸緩衝液にて洗浄した後回収し、B16メラノ
ーマ培養細胞の白色化度を以下の基準にて評価した。ま
た、比較例として既にメラニン生成抑制作用のあること
が知られている参考例3で得たヨクイニン抽出物につい
ても同様の試験を行った。Test Example 1 Inhibition of Melanin Production and Cell Viability Test by Cell Culture B16 melanoma cultured cells derived from mice were used. 2
An appropriate amount of a MEM medium containing 10% FBS was taken in a 6-well petri dish, B16 melanoma cells were inoculated, and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%. The next day, the final concentration of the cranberry fruit juice or the cranberry fruit extract obtained in Reference Example 1 was converted to a solid content of 0 (control), 60, 180,
The sample preparation was added and mixed to a concentration of 600 μg / mL. On the fifth day of the culture, the medium was replaced, and the sample preparation solution was added again. On the next day, the medium was removed, and one petri dish was washed with a phosphate buffer and then collected. The degree of whitening of the cultured B16 melanoma cells was evaluated according to the following criteria. Further, as a comparative example, the same test was performed on the yoquinin extract obtained in Reference Example 3 which is already known to have a melanin production inhibitory action.
【0051】(判定基準) +:対照に対してあきらかに白色である。 ±:対照に対してやや白色である。 −:対照と同じ黒色である。(Judgment Criteria) +: Clearly white with respect to the control. ±: slightly white compared to the control. -: Same black as the control.
【0052】残りの1枚のシャーレについて、細胞をホ
ルマリン固定後、1%クリスタルバイオレット溶液を添
加し染色した。各検体濃度に対する細胞生存率をモノセ
レーター(オリンパス社製)で測定した。以上の結果を
表1に示す。For the remaining one petri dish, the cells were fixed in formalin and stained with a 1% crystal violet solution. Cell viability for each sample concentration was measured with a monocerator (Olympus). Table 1 shows the above results.
【0053】(結果)(Result)
【表1】 [Table 1]
【0054】 *1 参考例1で製造したもの *2 参考例2で製造したもの *3 参考例3で製造したもの* 1 Manufactured in Reference Example 1 * 2 Manufactured in Reference Example 2 * 3 Manufactured in Reference Example 3
【0055】表1の結果から明らかなごとく、クランベ
リー果実搾汁液及び抽出物は高いメラニン生成抑制能を
有し、かつB16メラノーマ培養細胞に対し毒性が低い
ことが認められた。従って、クランベリー果実搾汁液及
び抽出物は、これを肌に適用することにより、極めて優
れたメラニン生成抑制作用を発揮し、日焼けによる肌の
黒色化、シミ、ソバカスなどを効果的に抑制し美白、美
肌効果が期待できる。As is evident from the results in Table 1, it was confirmed that the cranberry fruit juice and the extract had high melanin production inhibitory activity and low toxicity to cultured B16 melanoma cells. Therefore, the cranberry fruit juice and extract, by applying this to the skin, exerts an extremely excellent melanin production inhibitory effect, effectively suppresses skin blackening due to sunburn, spots, freckles, etc. A beautiful skin effect can be expected.
【0056】実施例1. クリーム 表2に示す組成及び下記製法でクリームを調製し、クラ
ンベリー果実搾汁液単独及びクランベリー果実搾汁液と
美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止
剤を併用した場合の美白、美肌効果を調べた。この結果
も表2に併せて示す。Embodiment 1 Cream A cream is prepared by the composition shown in Table 2 and the following production method, and whitening when using cranberry fruit juice alone or using a cranberry fruit juice with a whitening agent, an antioxidant, an anti-inflammatory agent, a cell activator, and a UV inhibitor. , The skin effect was examined. The results are also shown in Table 2.
【0057】(組成及び結果)(Composition and Results)
【表2】 [Table 2]
【0058】(製法) A.成分(1)〜(6)、(9)、(12)、(13)
を混合し、加熱して70℃に保つ。 B.成分(15)の一部を加熱して70℃に保つ。 C.AにBを加え、(7)、(14)及び(15)の残
部で溶解した(8)、(10)、(11)を混合した
後、冷却してクリームを得た。(Production method) Components (1) to (6), (9), (12), (13)
And heat to keep at 70 ° C. B. Heat a portion of component (15) and maintain at 70 ° C. C. B was added to A, and (8), (10) and (11) dissolved in the remainder of (7), (14) and (15) were mixed and cooled to obtain a cream.
【0059】(試験方法)被験クリーム1品につき27
〜54才の女性15名をパネルとし、毎日、朝と夜の2
回、洗顔後に被験クリームの適量を顔面に塗布した。試
験は12週間行った。塗布による美白、美肌効果を以下
の基準によって評価した。(Test method) 27 per test cream
Every day, morning and night 2
After washing the face, an appropriate amount of the test cream was applied to the face. The test was performed for 12 weeks. The whitening and skin effect by coating were evaluated according to the following criteria.
【0060】(評価基準) <評価> <内 容> 有 効 肌のくすみが目立たなくなった。 やや有効 肌のくすみがあまり目立たなくなった。 無 効 使用前と変化なし。(Evaluation Criteria) <Evaluation> <Contents> Effective Skin dullness became inconspicuous. Slightly effective Skin dullness became less noticeable. Ineffective No change from before use.
【0061】表2の結果に示される如く、クランベリー
果実搾汁液を配合した本発明品1のクリームは、これら
を皮膚に適用することにより、肌の「くすみ」等の発生
を防止、改善することができ、美しい肌とすることが明
らかであるが、さらに、クランベリー果実搾汁液と美白
剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を
併用して配合した本発明品2〜6を皮膚に適用すること
により、クランベリー果実搾汁液を単独で配合した外用
剤を適用した場合に比べてより優れた肌の「くすみ」等
の発生の防止、改善効果を相乗的に発揮し、美しい肌と
することが明らかとなった。As shown in the results in Table 2, the cream of the present invention 1 containing the juice of cranberry fruit can prevent and improve the occurrence of "dullness" on the skin by applying them to the skin. It is clear that it is possible to make beautiful skin, but in addition, the present invention product 2 which is combined with cranberry fruit juice and whitening agent, antioxidant, anti-inflammatory agent, cell activator, UV inhibitor By applying 6 to the skin, more effective prevention and improvement of the occurrence of "dullness" and the like of the skin than in the case of applying an external preparation containing only the cranberry fruit juice, It became clear to have beautiful skin.
【0062】 実施例2. 化粧水 (処方) (%) (1)グリセリン 10.0 (2)1,3−ブチレングリコール 6.0 (3)クランベリー果実の 50vol%1,3−ブチレングリコール抽出物*1 1.0 (4)クエン酸 0.1 (5)クエン酸ナトリウム 0.3 (6)精製水 残量 (7)ポリオキシエチレン(60E.O.) 硬化ヒマシ油 0.5 (8)エチルアルコール 8.0 (9)防腐剤 適量 (10)香料 適量 *1 参考例2で製造したものEmbodiment 2 Lotion (Prescription) (%) (1) Glycerin 10.0 (2) 1,3-butylene glycol 6.0 (3) 50 vol% 1,3-butylene glycol extract of cranberry fruit * 1 1.0 (4 ) Citric acid 0.1 (5) sodium citrate 0.3 (6) purified water balance (7) polyoxyethylene (60EO) hydrogenated castor oil 0.5 (8) ethyl alcohol 8.0 (9) ) Preservative appropriate amount (10) Fragrance appropriate amount * 1 manufactured in Reference Example 2
【0063】(製法) A.成分(1)〜(6)を混合溶解する。 B.成分(7)〜(10)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。(Production Method) The components (1) to (6) are mixed and dissolved. B. Components (7) to (10) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0064】実施例3. 化粧水 (処方) (%) (1)グリセリン 10.0 (2)1,3−ブチレングリコール 6.0 (3)クランベリー果実搾汁液*1 0.5 (4)海藻抽出物*2 0.5 (5)クエン酸 0.1 (6)クエン酸ナトリウム 0.3 (7)精製水 残量 (8)ポリオキシエチレン(60E.O.) 硬化ヒマシ油 0.5 (9)エチルアルコール 8.0 (10)防腐剤 適量 (11)香料 適量 *1 参考例1で製造したもの *2 丸善製薬社製Embodiment 3 FIG. Lotion (Prescription) (%) (1) Glycerin 10.0 (2) 1,3-butylene glycol 6.0 (3) Cranberry fruit juice * 1 0.5 (4) Seaweed extract * 2 0.5 (5) Citric acid 0.1 (6) Sodium citrate 0.3 (7) Purified water balance (8) Polyoxyethylene (60EO) hydrogenated castor oil 0.5 (9) Ethyl alcohol 8.0 (10) Appropriate amount of preservative (11) Appropriate amount of flavor * 1 Produced in Reference Example 1 * 2 Manufactured by Maruzen Pharmaceutical Co.
【0065】(製法) A.成分(1)〜(7)を混合溶解する。 B.成分(8)〜(11)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。(Production method) Components (1) to (7) are mixed and dissolved. B. Components (8) to (11) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0066】 実施例4. 乳液 (処方) (%) (1)モノステアリン酸ソルビタン 0.3 (2)モノオレイン酸ポリオキシエチレンソルビタン (20E.O.) 0.1 (3)親油型モノステアリン酸グリセリン 0.2 (4)ステアリン酸 0.5 (5)セタノール 0.5 (6)スクワラン 3.0 (7)流動パラフィン 4.0 (8)トリ2−エチルヘキサン酸グリセリル 2.0 (9)メチルポリシロキサン 1.0 (10)水素添加大豆リン脂質 0.1 (11)酢酸dl−α−トコフェロール*1 0.05 (12)防腐剤 適量 (13)カルボキシビニルポリマー 0.1 (14)水酸化ナトリウム 0.05 (15)グリセリン 5.0 (16)1,3−ブチレングリコール 7.0 (17)精製水 残量 (18)エチルアルコール 5.0 (19)クランベリー果実の 50vol%エチルアルコール抽出物*2 0.1 (20)甘草抽出物*3 1.0 (21)香料 適量 *1 エーザイ社製 *2 参考例2で製造したもの *3 丸善製薬社製Embodiment 4 FIG. Emulsion (Formulation) (%) (1) Sorbitan monostearate 0.3 (2) Polyoxyethylene sorbitan monooleate (20EO) 0.1 (3) Lipophilic glyceryl monostearate 0.2 ( 4) Stearic acid 0.5 (5) Cetanol 0.5 (6) Squalane 3.0 (7) Liquid paraffin 4.0 (8) Glyceryl tri-2-ethylhexanoate 2.0 (9) Methyl polysiloxane 1. 0 (10) Hydrogenated soybean phospholipid 0.1 (11) dl-α-tocopherol acetate * 1 0.05 (12) Preservative appropriate amount (13) Carboxyvinyl polymer 0.1 (14) Sodium hydroxide 0.05 (15) Glycerin 5.0 (16) 1,3-butylene glycol 7.0 (17) Remaining amount of purified water (18) Ethyl alcohol 5.0 (19) Crambe 50 vol% ethyl alcohol extract of chromatography fruit * 2 0.1 (20) licorice extract * 3 1.0 (21) Perfume Appropriate amount * 1 Eisai Co. * 2 as prepared in Reference Example 2 * 3 Maruzen Pharmaceuticals Co., Ltd.
【0067】(製法) A.成分(13)〜(17)を加熱混合し、70℃に保
つ。 B.成分(1)〜(12)を加熱混合し、70℃に保
つ。 C.AにBを加えて混合し、均一に乳化する。 D.Cを冷却後(18)〜(21)を加え、均一に混合
して乳液を得た。(Production Method) The components (13) to (17) are mixed by heating and kept at 70 ° C. B. The components (1) to (12) are mixed by heating and kept at 70 ° C. C. Add B to A, mix and emulsify uniformly. D. After cooling C, (18) to (21) were added and mixed uniformly to obtain an emulsion.
【0068】 実施例5. 乳液 (処方) (%) (1)モノステアリン酸ソルビタン 0.3 (2)モノオレイン酸ポリオキシエチレンソルビタン (20E.O.) 0.1 (3)親油型モノステアリン酸グリセリン 0.2 (4)ステアリン酸 0.5 (5)セタノール 0.5 (6)スクワラン 3.0 (7)流動パラフィン 4.0 (8)トリ2−エチルヘキサン酸グリセリル 2.0 (9)メチルポリシロキサン 1.0 (10)水素添加大豆リン脂質 0.1 (11)アスタキサンチン*1 0.2 (12)防腐剤 適量 (13)カルボキシビニルポリマー 0.1 (14)水酸化ナトリウム 0.05 (15)グリセリン 5.0 (16)1,3−ブチレングリコール 7.0 (17)精製水 残量 (18)エチルアルコール 5.0 (19)クランベリー果実搾汁液*2 0.5 (20)酵母抽出物*3 3.0 (21)ヒアルロン酸ナトリウム 0.5 (22)香料 適量 *1 シグマ社製 *2 参考例1で製造したもの *3 丸善製薬社製Embodiment 5 FIG. Emulsion (Formulation) (%) (1) Sorbitan monostearate 0.3 (2) Polyoxyethylene sorbitan monooleate (20EO) 0.1 (3) Lipophilic glyceryl monostearate 0.2 ( 4) Stearic acid 0.5 (5) Cetanol 0.5 (6) Squalane 3.0 (7) Liquid paraffin 4.0 (8) Glyceryl tri-2-ethylhexanoate 2.0 (9) Methyl polysiloxane 1. 0 (10) Hydrogenated soybean phospholipid 0.1 (11) Astaxanthin * 1 0.2 (12) Preservative appropriate amount (13) Carboxyvinyl polymer 0.1 (14) Sodium hydroxide 0.05 (15) Glycerin 5 0.0 (16) 1,3-butylene glycol 7.0 (17) Remaining purified water (18) Ethyl alcohol 5.0 (19) Cranberry fruit juice * 2 0.5 (20) Yeast extract * 3 3.0 (21) Sodium hyaluronate 0.5 (22) Appropriate amount of flavor * 1 Sigma * 2 Manufactured in Reference Example 1 * 3 Maruzen Pharmaceutical
【0069】(製法) A.成分(13)〜(17)を加熱混合し、70℃に保
つ。 B.成分(1)〜(12)を加熱混合し、70℃に保
つ。 C.AにBを加えて混合し、均一に乳化する。 D.Cを冷却後(18)〜(22)を加え、均一に混合
して乳液を得た。(Production method) The components (13) to (17) are mixed by heating and kept at 70 ° C. B. The components (1) to (12) are mixed by heating and kept at 70 ° C. C. Add B to A, mix and emulsify uniformly. D. After cooling C, (18) to (22) were added and mixed uniformly to obtain an emulsion.
【0070】実施例2、3、4及び実施例5はいずれも
経時安定性に優れ、皮膚に適用することにより、日焼け
による肌の「くすみ」やシミやソバカスを防止し、透明
感のある美しい肌にする化粧水及び乳液であった。Examples 2, 3, 4, and 5 all have excellent stability over time, and when applied to the skin, can prevent skin dullness, spots, and freckles due to sunburn, and are transparent and beautiful. Lotion and milky lotion to make skin.
【0071】 実施例6. 軟膏 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)dl−α−トコフェロール*1 0.2 (4)防腐剤 適量 (5)トリエタノールアミン 2.0 (6)グリセリン 5.0 (7)精製水 残量 (8)クランベリー果実の 50vol%1,3−ブチレングリコール抽出物*2 1.0 (9)グリチルレチン酸ステアリル*3 0.5 *1 エーザイ社製 *2 参考例2で製造したもの *3 丸善製薬社製Embodiment 6 FIG. Ointment (Formulation) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) dl-α-tocopherol * 1 0.2 (4) Preservatives Appropriate amount (5) Triethanolamine 2.0 (6) Glycerin 5.0 (7) Remaining purified water (8) 50 vol% 1,3-butylene glycol extract of cranberry fruit * 2 1.0 (9) Stearyl glycyrrhetinate * 3 0.5 * 1 Eisai * 2 Manufactured in Reference Example 2 * 3 Maruzen Pharmaceutical
【0072】(製法) A.成分(5)、(6)及び(7)の一部を加熱混合
し、75℃に保つ。 B.成分(1)〜(4)、(9)を加熱混合し、75℃
に保つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(7)の残部で溶解した(8)を
加え、軟膏を得た。(Production Method) A part of components (5), (6) and (7) are mixed by heating and kept at 75 ° C. B. Heat and mix components (1) to (4) and (9),
To keep. C. Add A slowly to B. D. While cooling C, (8) dissolved in the remainder of (7) was added to obtain an ointment.
【0073】 実施例7. 軟膏 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)防腐剤 適量 (4)トリエタノールアミン 2.0 (5)グリセリン 5.0 (6)精製水 残量 (7)クランベリーの 50vol%エチルアルコール抽出物*1 2.0 (8)イチョウ抽出物*2 0.3 (9)ピロリドンカルボン酸ナトリウム*3 0.3 *1 参考例2で製造したもの *2 常磐植物化学研究所社製 *3 味の素社製Embodiment 7 Ointment (Prescription) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Preservative appropriate amount (4) Triethanolamine 2.0 (5) Glycerin 5.0 (6) Purified water residue Amount (7) 50 vol% ethyl alcohol extract of cranberry * 1 2.0 (8) Ginkgo extract * 2 0.3 (9) Sodium pyrrolidonecarboxylate * 3 0.3 * 1 Produced in Reference Example 2 * 2 Tokiwa Plant Chemical Laboratory * 3 Ajinomoto
【0074】(製法) A.成分(4)、(5)及び(6)の一部を加熱混合
し、75℃に保つ。 B.成分(1)〜(3)を加熱混合し、75℃に保つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(6)の残部で溶解した(7)〜
(9)を加え、軟膏を得た。(Production method) A part of components (4), (5) and (6) are mixed by heating and kept at 75 ° C. B. Components (1) to (3) are mixed by heating and kept at 75 ° C. C. Add A slowly to B. D. C was dissolved in the remainder of (6) while cooling (7)-
(9) was added to obtain an ointment.
【0075】実施例6、7は経時安定性に優れ、皮膚に
適用することにより、肌の「くすみ」やシミやソバカス
を防止し、透明感のある美しい肌にする軟膏であった。Examples 6 and 7 were ointments which were excellent in stability over time and applied to the skin to prevent "dullness", spots and freckles on the skin, and to make the skin transparent and beautiful.
【0076】実施例8. パック (処方) (%) (1)ポリビニルアルコール 15.0 (2)無水ケイ酸 0.5 (3)ポリエチレングリコール 0.5 (4)ポリオキシプロピレン メチルグルコシド 5.0 (5)グリセリン 5.0 (6)精製水 残量 (7)エチルアルコール 20.0 (8)防腐剤 適量 (9)クランベリー果実搾汁液*1 0.2 (10)アルニカ抽出物*2 0.2 (11)ニンジン抽出物*3 0.2 (12)香料 適量 *1 参考例1で製造したもの *2 丸善製薬社製 *3 丸善製薬社製Embodiment 8 FIG. (Prescription) (%) (1) Polyvinyl alcohol 15.0 (2) Silicic anhydride 0.5 (3) Polyethylene glycol 0.5 (4) Polyoxypropylene methyl glucoside 5.0 (5) Glycerin 5.0 (6) Remaining purified water (7) Ethyl alcohol 20.0 (8) Preservative appropriate amount (9) Cranberry fruit juice * 1 0.2 (10) Arnica extract * 2 0.2 (11) Carrot extract * 3 0.2 (12) Appropriate amount of fragrance * 1 Manufactured in Reference Example 1 * 2 Maruzen Pharmaceutical * 3 Maruzen Pharmaceutical
【0077】(製法) A.成分(1)〜(6)を混合し、70℃に加熱し、撹
拌する。 B.成分(7)及び(8)を混合する。 C.上記Bを先のAに加え、混合した後、冷却して
(9)〜(12)を均一に分散してパックを得た。(Production Method) Mix components (1)-(6), heat to 70 ° C. and stir. B. Mix components (7) and (8). C. The above B was added to the above A, mixed, cooled, and (9) to (12) were uniformly dispersed to obtain a pack.
【0078】 実施例9. パック (処方) (%) (1)ポリビニルアルコール 15.0 (2)無水ケイ酸 0.5 (3)ポリエチレングリコール 0.5 (4)ポリオキシプロピレンメチルグルコシド 5.0 (5)グリセリン 5.0 (6)精製水 残量 (7)エチルアルコール 20.0 (8)防腐剤 適量 (9)クランベリー果実の 50%1,3−ブチレングリコール抽出物*1 0.5 (10)ヨクイニン抽出物*2 0.5 (11)加水分解コンキオリン液*3 0.5 (12)コムギ抽出物*4 0.5 (13)香料 適量 *1 参考例2で製造したもの *2 参考例3で製造したもの *3 丸善製薬社製 *4 成和化成社製Embodiment 9 FIG. (Prescription) (%) (1) Polyvinyl alcohol 15.0 (2) Silicic anhydride 0.5 (3) Polyethylene glycol 0.5 (4) Polyoxypropylene methyl glucoside 5.0 (5) Glycerin 5.0 (6) Remaining purified water (7) Ethyl alcohol 20.0 (8) Preservative appropriate amount (9) 50% 1,3-butylene glycol extract of cranberry fruit * 1 0.5 (10) Yokuinin extract * 2 0.5 (11) Hydrolyzed conchiolin solution * 3 0.5 (12) Wheat extract * 4 0.5 (13) Perfume appropriate amount * 1 Produced in Reference Example 2 * 2 Produced in Reference Example 3 * 3 Maruzen Pharmaceutical Co., Ltd. * 4 Seiwa Chemical Co., Ltd.
【0079】(製法) A.成分(1)〜(7)を混合し、70℃に加熱し、撹
拌する。 B.成分(8)及び(9)を混合する。 C.上記Bを先のAに加え、混合した後、冷却して(1
0)〜(13)を均一に分散してパックを得た。(Production method) Mix components (1)-(7), heat to 70 ° C. and stir. B. Mix components (8) and (9). C. The above B was added to the above A, mixed and then cooled (1
0) to (13) were uniformly dispersed to obtain a pack.
【0080】実施例8及び9は経時安定性に優れ、皮膚
に適用することにより、肌の「くすみ」やシミを防止
し、透明感のある美しい肌にするパックであった。Examples 8 and 9 were packs which were excellent in stability over time and applied to the skin to prevent "dullness" and spots on the skin and to make the skin transparent and beautiful.
【0081】実施例10. リキッドファンデーショ
ン: (処方) (%) (1)液状ラノリン 2.0 (2)流動パラフィン 5.0 (3)ステアリン酸 2.0 (4)セタノール 1.0 (5)自己乳化型 モノステアリン酸グリセリン 1.0 (6)パラメトキシケイ皮酸 8.0 −2−エチルヘキシル (7)防腐剤 適量 (8)グリセリン 5.0 (9)トリエタノールアミン 1.0 (10)カルボキシメチルセルロース 0.2 (11)ベントナイト 0.5 (12)精製水 残量 (13)酸化チタン 6.0 (14)微粒子酸化チタン 2.0 (15)微粒子酸化亜鉛 5.0 (16)マイカ 2.0 (17)タルク 4.0 (18)着色顔料 4.0 (19)クランベリー果実搾汁液*1 0.01 (20)カンゾウ抽出物*2 0.5 (21)イラクサ抽出物*3 0.5 (22)香料 適量 *1 参考例1で製造したもの *2 丸善製薬社製 *3 丸善製薬社製Embodiment 10 FIG. Liquid foundation: (Formulation) (%) (1) Liquid lanolin 2.0 (2) Liquid paraffin 5.0 (3) Stearic acid 2.0 (4) Cetanol 1.0 (5) Self-emulsifying glyceryl monostearate 1.0 (6) Paramethoxycinnamic acid 8.0-2-ethylhexyl (7) Preservative appropriate amount (8) Glycerin 5.0 (9) Triethanolamine 1.0 (10) Carboxymethylcellulose 0.2 (11) ) Bentonite 0.5 (12) Purified water Remaining (13) Titanium oxide 6.0 (14) Fine titanium oxide 2.0 (15) Fine zinc oxide 5.0 (16) Mica 2.0 (17) Talc 4 0.0 (18) Color pigment 4.0 (19) Cranberry fruit juice * 1 0.01 (20) Licorice extract * 2 0.5 (21) Nettle extract * 30 .5 (22) Appropriate amount of perfume * 1 Produced in Reference Example 1 * 2 Maruzen Pharmaceutical Co. * 3 Maruzen Pharmaceutical Co.
【0082】(製法) A.成分(1)〜(7)を混合溶解する。 B.Aに成分(13)〜(18)を加え、均一に混合
し、70℃に保つ。 C.成分(8)〜(12)を均一に溶解し、70℃に保
つ。 D.CにBを添加して、均一に乳化する。 E.Dを冷却後、成分(19)〜(22)を添加してリ
キッドファンデーションを得た。(Production Method) A. Components (1) to (7) are mixed and dissolved. B. Add components (13) to (18) to A, mix uniformly, and keep at 70 ° C. C. Components (8) to (12) are uniformly dissolved and kept at 70 ° C. D. Add B to C and emulsify uniformly. E. FIG. After cooling D, components (19) to (22) were added to obtain a liquid foundation.
【0083】 実施例11. リキッドファンデーション: (処方) (%) (1)液状ラノリン 2.0 (2)流動パラフィン 5.0 (3)ステアリン酸 2.0 (4)セタノール 1.0 (5)自己乳化型 モノステアリン酸グリセリン 1.0 (6)パラメトキシケイ皮酸 8.0 −2−エチルヘキシル (7)4−tert−ブチル−4’ −メトキシジベンゾイルメタン 2.0 (8)パルミチン酸レチノール*1 0.2 (9)防腐剤 適量 (10)グリセリン 5.0 (11)トリエタノールアミン 1.0 (12)カルボキシメチルセルロース 0.2 (13)ベントナイト 0.5 (14)精製水 残量 (15)酸化チタン 6.0 (16)微粒子酸化チタン 2.0 (17)微粒子酸化亜鉛 2.0 (18)マイカ 2.0 (19)タルク 4.0 (20)着色顔料 4.0 (21)クランベリー果実搾汁液*2 0.2 (22)α−グルコシルルチン*3 0.5 (23)リン酸−L−アスコルビルマグネシウム*4 0.5 (24)香料 適量 *1 日本ロシュ社製 *2 参考例1で製造したもの *3 東洋製糖社製 *4 日光ケミカルズ社製Embodiment 11 FIG. Liquid foundation: (Formulation) (%) (1) Liquid lanolin 2.0 (2) Liquid paraffin 5.0 (3) Stearic acid 2.0 (4) Cetanol 1.0 (5) Self-emulsifying glyceryl monostearate 1.0 (6) Paramethoxycinnamic acid 8.0-2-ethylhexyl (7) 4-tert-butyl-4'-methoxydibenzoylmethane 2.0 (8) Retinol palmitate * 1 0.2 (9 ) Preservative suitable amount (10) Glycerin 5.0 (11) Triethanolamine 1.0 (12) Carboxymethylcellulose 0.2 (13) Bentonite 0.5 (14) Remaining purified water (15) Titanium oxide 6.0 (16) Fine particle titanium oxide 2.0 (17) Fine particle zinc oxide 2.0 (18) Mica 2.0 (19) Talc 4.0 (20) Color pigment 2.0 (21) Cranberry fruit juice * 2 0.2 (22) α-glucosylrutin * 3 0.5 (23) Phosphorus-L-ascorbyl magnesium * 4 0.5 (24) Perfume appropriate amount * 1 Nippon Roche * 2 Manufactured in Reference Example 1 * 3 Toyo Sugar Co. * 4 Nikko Chemicals
【0084】(製法) A.成分(1)〜(9)を混合溶解する。 B.Aに成分(15)〜(20)を加え、均一に混合
し、70℃に保つ。 C.成分(10)〜(14)、(22)、(23)を均
一に溶解し、70℃に保つ。 D.CにBを添加して、均一に乳化する。 E.Dを冷却後、成分(21)及び(24)を添加して
リキッドファンデーションを得た。(Production Method) A. Components (1) to (9) are mixed and dissolved. B. Add components (15) to (20) to A, mix uniformly, and keep at 70 ° C. C. Components (10) to (14), (22) and (23) are uniformly dissolved and kept at 70 ° C. D. Add B to C and emulsify uniformly. E. FIG. After cooling D, components (21) and (24) were added to obtain a liquid foundation.
【0085】 実施例12. 日やけ止め乳液 (処方) (%) (1)ポリオキシアルキレン変性 オルガノポリシロキサン 1.0 (2)ジメチルポリシロキサン 5.0 (3)オクタメチルシクロテトラシロキサン 20.0 (4)イソノナン酸イソトリデシル 5.0 (5)パラメトキシケイ皮酸 −2−エチルヘキシル 5.0 (6)防腐剤 適量 (7)香料 適量 (8)シリコン処理微粒子酸化チタン 10.0 (9)シリコン処理微粒子酸化亜鉛 10.0 (10)ポリスチレン末 3.0 (11)トリメチルシロキシケイ酸 0.5 (12)ジプロピレングリコール 3.0 (13)エチルアルコール 10.0 (14)精製水 残量 (15)食塩 0.2 (16)クランベリー果実の 50vol%エチルアルコール抽出物*1 2.0 (17)ビャクレン抽出物*2 3.0 *1 参考例2で製造したもの *2 サントリー社製Embodiment 12 FIG. Sunscreen emulsion (Prescription) (%) (1) Polyoxyalkylene-modified organopolysiloxane 1.0 (2) Dimethylpolysiloxane 5.0 (3) Octamethylcyclotetrasiloxane 20.0 (4) Isotridecyl isononanoate 5 0.0 (5) 2-Ethylhexyl paramethoxycinnamic acid 5.0 (6) Preservative appropriate amount (7) Perfume appropriate amount (8) Silicon-treated fine particle titanium oxide 10.0 (9) Silicon-treated fine particle zinc oxide 10.0 (10) Polystyrene powder 3.0 (11) Trimethylsiloxysilicate 0.5 (12) Dipropylene glycol 3.0 (13) Ethyl alcohol 10.0 (14) Remaining purified water (15) Salt 0.2 ( 16) 50 vol% ethyl alcohol extract of cranberry fruit * 1 2.0 (17) Rosewood extract * 23 0 * 1 as prepared in Reference Example 2 * 2 Suntory Ltd.
【0086】(製法) A.成分(1)〜(11)を混合分散する。 B.成分(12)〜(15)を混合分散する。 C.AにBを添加して、均一に乳化する。 D.Cに成分(16)、(17)を添加して日やけ止め
乳液を得た。(Production method) Components (1) to (11) are mixed and dispersed. B. Components (12) to (15) are mixed and dispersed. C. Add B to A and emulsify uniformly. D. The components (16) and (17) were added to C to obtain a sunscreen emulsion.
【0087】実施例13. 日やけ止め乳液 (処方) (%) (1)ポリオキシアルキレン変性 オルガノポリシロキサン 1.0 (2)ジメチルポリシロキサン 5.0 (3)オクタメチルシクロテトラシロキサン 20.0 (4)イソノナン酸イソトリデシル 5.0 (5)パラメトキシケイ皮酸 −2−エチルヘキシル 10.0 (6)防腐剤 適量 (7)香料 適量 (8)シリコン処理微粒子酸化チタン 5.0 (9)シリコン処理微粒子酸化亜鉛 5.0 (10)ポリスチレン末 3.0 (11)トリメチルシロキシケイ酸 0.5 (12)ジプロピレングリコール 3.0 (13)エチルアルコール 10.0 (14)精製水 残量 (15)食塩 0.2 (16)クランベリー果実搾汁液*1 1.0 (17)リン酸−L−アスコルビル マグネシウム*2 3.0 (18)ウーロン茶抽出物*3 0.5 *1 参考例1で製造したもの *2 日光ケミカルズ社製 *3 丸善製薬社製Embodiment 13 FIG. Sunscreen emulsion (Prescription) (%) (1) Polyoxyalkylene-modified organopolysiloxane 1.0 (2) Dimethylpolysiloxane 5.0 (3) Octamethylcyclotetrasiloxane 20.0 (4) Isotridecyl isononanoate 5 2.0 (5) Paramethoxycinnamic acid-2-ethylhexyl 10.0 (6) Preservative proper amount (7) Fragrance proper amount (8) Silicon-treated fine particle titanium oxide 5.0 (9) Silicon-treated fine particle zinc oxide 5.0 (10) Polystyrene powder 3.0 (11) Trimethylsiloxysilicate 0.5 (12) Dipropylene glycol 3.0 (13) Ethyl alcohol 10.0 (14) Remaining purified water (15) Salt 0.2 ( 16) Cranberry fruit juice * 1 1.0 (17) Magnesium phosphate-L-ascorbyl * 2 3.0 (18) Oolong tea extract * 3 0.5 * 1 Produced in Reference Example 1 * 2 Nikko Chemicals * 3 Maruzen Pharmaceutical
【0088】(製法) A.成分(1)〜(11)を混合分散する。 B.成分(12)〜(15)を混合分散する。 C.AにBを添加して、均一に乳化する。 D.Cに成分(16)〜(18)を添加して日やけ止め
乳液を得た。(Production method) Components (1) to (11) are mixed and dispersed. B. Components (12) to (15) are mixed and dispersed. C. Add B to A and emulsify uniformly. D. The components (16) to (18) were added to C to obtain a sunscreen emulsion.
【0089】実施例10〜13は経時安定性に優れ、皮
膚に適用することにより、日焼け等による肌の黒化やシ
ミやソバカスを防止する効果に優れるリキッドファンデ
ーション及び日やけ止め乳液であった。Examples 10 to 13 are liquid foundations and sunscreen emulsions which are excellent in stability over time and which are excellent in the effects of applying to the skin to prevent darkening of the skin due to sunburn, spots and freckles.
【0090】[0090]
【発明の効果】以上のごとく、本発明のクランベリー果
実搾汁液及び/又はクランベリー果実抽出物を含有する
皮膚外用剤は、メラニン生成抑制作用及びを有してお
り、色素沈着に対し高い抑制効果を発揮し、肌のくす
み、日やけなどによる皮膚の黒化、シミ、ソバカスの防
止及び改善等に有効である。As described above, the external preparation for skin containing the cranberry fruit juice and / or the cranberry fruit extract of the present invention has a melanin production inhibitory effect and a high inhibitory effect on pigmentation. It is effective in preventing and improving skin darkening due to dull skin, sunburn, etc., spots and freckles.
【0091】また、クランベリー果実搾汁液及び/又は
クランベリー果実抽出物のほか、美白剤、抗酸化剤、抗
炎症剤、細胞賦活剤、紫外線防止剤等の他の薬効成分を
配合した本発明の皮膚外用剤は、前記抽出物を単独で配
合した場合に比べてより優れた美白、美肌効果を有する
ものである。The skin according to the present invention, which contains, in addition to cranberry fruit juice and / or cranberry fruit extract, other medicinal ingredients such as whitening agents, antioxidants, anti-inflammatory agents, cell activators, and UV inhibitors. The external preparation has a more excellent whitening and skin beautiful effect as compared with the case where the extract is blended alone.
【0092】従って、本発明の皮膚外用剤は、美白、美
肌を目的とする化粧品や医薬品等として有利に利用する
ことができるものである。Therefore, the external preparation for skin of the present invention can be advantageously used as cosmetics or pharmaceuticals for whitening and beautiful skin.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/16 A61P 17/16 Fターム(参考) 4C083 AA032 AA082 AA111 AA112 AB032 AB172 AB212 AB242 AB432 AB442 AC022 AC072 AC102 AC122 AC212 AC242 AC302 AC342 AC422 AC432 AC442 AC542 AC612 AC912 AD022 AD042 AD092 AD112 AD152 AD162 AD172 AD272 AD332 AD392 AD412 AD512 AD532 AD572 AD642 AD662 BB46 BB47 BB51 CC02 CC03 CC04 CC05 CC07 CC12 CC19 DD22 DD23 DD31 EE12 EE16 EE17 4C084 AA19 MA02 MA63 NA05 NA14 ZA891 ZB221 4C088 AB12 AC04 BA08 CA03 MA01 MA63 NA05 NA14 ZA89 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61P 17/16 A61P 17/16 F-term (Reference) 4C083 AA032 AA082 AA111 AA112 AB032 AB172 AB212 AB242 AB432 AB442 AC022 AC072 AC102 AC122 AC212 AC242 AC302 AC342 AC422 AC432 AC442 AC542 AC612 AC912 AD022 AD042 AD092 AD112 AD152 AD162 AD172 AD272 AD332 AD392 AD412 AD512 AD532 AD572 AD642 AD662 BB46 BB47 BB51 CC02 CC03 CC04 CC05 CC07 CC12 CC19 DD22 DD23 DD31 EE12 EA4 MA14 NA14 MA14 MA14 MA14 ZB221 4C088 AB12 AC04 BA08 CA03 MA01 MA63 NA05 NA14 ZA89
Claims (3)
ンベリー果実抽出物を含有することを特徴とする皮膚外
用剤。1. An external preparation for skin, comprising cranberry fruit juice and / or cranberry fruit extract.
ンベリー果実抽出物を美白、美肌成分として含有するこ
とを特徴とする請求項1記載の皮膚外用剤。2. The external preparation for skin according to claim 1, which comprises a cranberry fruit juice and / or a cranberry fruit extract as a whitening and beautiful skin component.
果実抽出物 (B)美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外
線防止剤から選ばれる薬効剤の一種又は二種以上を含有
することを特徴とする皮膚外用剤。3. The following components (A) and (B): (A) cranberry fruit juice and / or cranberry fruit extract; (B) whitening agent, antioxidant, anti-inflammatory agent, cell activator, ultraviolet ray inhibitor An external preparation for skin, characterized by containing one or more kinds of pharmaceutically active agents selected from the group consisting of:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001080389A JP2002275080A (en) | 2001-03-21 | 2001-03-21 | Skin care preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001080389A JP2002275080A (en) | 2001-03-21 | 2001-03-21 | Skin care preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002275080A true JP2002275080A (en) | 2002-09-25 |
Family
ID=18936684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001080389A Pending JP2002275080A (en) | 2001-03-21 | 2001-03-21 | Skin care preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002275080A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2015124182A (en) * | 2013-12-26 | 2015-07-06 | 日本メナード化粧品株式会社 | Sebum synthesis accelerator |
-
2001
- 2001-03-21 JP JP2001080389A patent/JP2002275080A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2015124182A (en) * | 2013-12-26 | 2015-07-06 | 日本メナード化粧品株式会社 | Sebum synthesis accelerator |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005220084A (en) | Acerola seed extract-containing composition | |
JP5571280B2 (en) | Sebum production promoter | |
KR20050084971A (en) | Composition for preparation for external use on skin and method of using the same | |
JP2001261570A (en) | Skin care preparation | |
JP2007210915A (en) | Skin preparation for external use | |
JP2001031558A (en) | Skin lotion | |
JP2003063925A (en) | Skin care preparation | |
JP2002212087A (en) | Skin care preparation | |
JP2004010526A (en) | Skin care preparation for external use | |
JP3987793B2 (en) | Topical skin preparation | |
JP2004196669A (en) | Melanocyte proliferation inhibitor and skin care preparation for external use comprising the same | |
JP2002138027A (en) | External preparation for skin | |
JP2002332224A (en) | Anti-ageing skin care preparation and anti-ageing skin care preparation composition | |
JP3754646B2 (en) | Topical skin preparation | |
JP4203325B2 (en) | Skin external preparation and skin external preparation composition | |
JP2002275081A (en) | Skin care preparation | |
JP4035481B2 (en) | Skin preparation | |
JP2004051492A (en) | Antiaging agent or cell activator and external preparation for skin comprising the same | |
JP2003160463A (en) | Skin care preparation | |
JP2002275018A (en) | Skin care preparation | |
JP4713032B2 (en) | Skin preparation | |
JP2003252742A (en) | Melanocyte dendrite formation inhibitor and skin care preparation containing the same | |
JP2007238597A (en) | Skin care preparation | |
JP3895636B2 (en) | Anti-aging agent and external preparation for skin using the same | |
JP2004137233A (en) | Antiaging agent and external preparation for skin using the same |